1
|
Rodrigues M, Eberst L, Follana P, Gauthier L, Jacquemin V, Tessier C, El Mouaddin N, Boudier P, Fiteni F, Angeli E, Roche S, Delanoy N, Sabatier R, Flippot R, de la Motte Rouge T. Real-world dostarlimab use in advanced/recurrent endometrial cancer in France. Bull Cancer 2023; 110:1041-1050. [PMID: 37659907 DOI: 10.1016/j.bulcan.2023.06.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2023] [Accepted: 06/12/2023] [Indexed: 09/04/2023]
Abstract
INTRODUCTION In October 2020, the French Health Authority granted early access outside of the clinical trial setting for dostarlimab, a programmed death-1 inhibitor. Dostarlimab was approved by the European Medicines Agency (in April 2021) as monotherapy for patients with post-platinum mismatch repair deficient/microsatellite instability-high advanced/recurrent endometrial cancer, based on the results of the GARNET trial (NCT02715284). METHODS This was a real-world descriptive analysis of patients granted cohort temporary authorization of use to receive dostarlimab between November 2020 and June 2021. Physicians could complete follow-up forms at each treatment cycle to provide clinical information, safety, and efficacy data. Safety and disease progression data were also captured through pharmacovigilance reports. RESULTS Of 95 temporary authorization of use requests made by 80 oncologists in 59 French hospitals, 87 patients were eligible, and 80 received≥1 dose of dostarlimab. Based on treatment response assessments received (n=43), the mean (standard deviation) time from treatment initiation to response evaluation was 11 (6) weeks. The disease control rate (complete plus partial responses plus stable disease rates) was 56% (n=24/43), and the overall response rate was 35% (n=15/43); both consistent with those reported in the GARNET trial. No new safety signals were reported. DISCUSSION The enrolment of 80 patients in an 8-month period highlights the need for access to novel treatment regimens in France for these patients post-platinum. Prospective randomized studies are ongoing to assess the efficacy and safety of dostarlimab and other checkpoint inhibitors as first-line treatment in patients with endometrial cancer.
Collapse
Affiliation(s)
- Manuel Rodrigues
- Institut Curie, département d'oncologie médicale et Inserm U830, Paris, France.
| | - Lauriane Eberst
- Institut de cancérologie de Strasbourg Europe, Strasbourg, France; Agence nationale de sécurité du médicament, Saint Denis, France
| | | | | | | | | | | | - Philippe Boudier
- Institut de cancérologie de Strasbourg Europe, Strasbourg, France; Agence nationale de sécurité du médicament, Saint Denis, France
| | - Frederic Fiteni
- Centre hospitalier universitaire de Nîmes, Nîmes/UMR Inserm IDESP, institut Desbret d'épidémiologie et de santé publique, université de Montpellier, service d'oncologie médicale, 34090 Montpellier, France
| | - Eurydice Angeli
- Hôpital Avicenne, service d'oncologie médicale, Bobigny, France
| | | | - Nicolas Delanoy
- AP-HP, institut du cancer Paris CARPEM, hôpital européen Georges-Pompidou, department of medical oncology, Paris, France
| | - Renaud Sabatier
- Aix-Marseille université, Inserm, institut Paoli-Calmettes, department of medical oncology, Marseille, France
| | - Ronan Flippot
- Gustave-Roussy, Paris Saclay university, department of cancer medicine, Villejuif, France
| | | |
Collapse
|
2
|
Ritter C, Koralesky KE, Saraceni J, Roche S, Vaarst M, Kelton D. Invited review: Qualitative research in dairy science-A narrative review. J Dairy Sci 2023; 106:5880-5895. [PMID: 37474366 DOI: 10.3168/jds.2022-23125] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/07/2022] [Accepted: 02/23/2023] [Indexed: 07/22/2023]
Abstract
The use of qualitative research in dairy science has increased considerably in recent years, providing the opportunity to inform research and practice. This review aims to enhance the accessibility of qualitative research among a range of audiences and specifically: (1) provide an overview of what qualitative research is and the value it can bring to scientific inquiries in the dairy context, (2) illustrate the emergence of qualitative dairy science research in the past 15 to 20 years, (3) outline the role of the researcher and key philosophical assumptions underlying qualitative research, (4) describe qualitative research approaches and methods used in dairy science research, and (5) highlight key aspects of qualitative inquiry used to ensure research trustworthiness. Qualitative approaches in dairy science enable researchers to understand myriad topics including stakeholder relationships, decision-making, and behaviors regarding dairy cattle management, animal welfare, and disease prevention and control measures. Approaches that were used often for qualitative data collection were individual interviews and focus groups, and variations of thematic analysis were common analytical frameworks. To assess public values, attitudes, and perceptions, mixed methods questionnaires that combined quantitative data with qualitative data from open-ended questions were used regularly. Although still used infrequently, action research and participatory approaches have the potential to bridge the research-implementation gap by facilitating group-based learning and on-farm changes. Some publications described the philosophical assumptions inherent to qualitative research, and many authors included reflexivity and positionality statements. Although a comprehensive description of strategies to meet trustworthiness criteria for qualitative research was uncommon, many publications mentioned certain aspects of trustworthiness, such as member checking, researcher triangulation, and the recording of reflexive notes. Qualitative research has been used to deepen our understanding of phenomena relevant to the dairy sector and has opened the door for a broad array of new opportunities. In addition to having merit on its own, qualitative research can guide, inform, and expand on quantitative research, and an understanding of the core pillars of qualitative research can foster interdisciplinary collaborations.
Collapse
Affiliation(s)
- C Ritter
- Department of Health Management, Atlantic Veterinary College, University of Prince Edward Island, Charlottetown, Canada, C1A 4P3.
| | - K E Koralesky
- Animal Welfare Program, Faculty of Land and Food Systems, The University of British Columbia, Vancouver, Canada, V6T 1Z4
| | - J Saraceni
- ACER Consulting Ltd., Guelph, Ontario, Canada, N1G 5L3
| | - S Roche
- ACER Consulting Ltd., Guelph, Ontario, Canada, N1G 5L3; Department of Population Medicine, University of Guelph, Guelph, Ontario, Canada, N1G 2W1
| | - M Vaarst
- Department of Animal and Veterinary Sciences, Aarhus University, Tjele, Denmark, DK-8830
| | - D Kelton
- Department of Population Medicine, University of Guelph, Guelph, Ontario, Canada, N1G 2W1
| |
Collapse
|
3
|
Roche S, Renaud DL, Bauman CA, Lombard J, Short D, Saraceni J, Kelton DF. Calf management and welfare in the Canadian and US dairy industries: Where do we go from here? J Dairy Sci 2023; 106:4266-4274. [PMID: 37080780 DOI: 10.3168/jds.2022-22793] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2022] [Accepted: 12/22/2022] [Indexed: 04/22/2023]
Abstract
The objective of this narrative review was to compare the results of the 2015 Canadian National Dairy Study and the 2014 US National Animal Health Monitoring System (NAHMS) Dairy Studies, with a specific focus on calf management and welfare, and to interpret these findings within more recent calf health research to describe where we need to go next in the North American dairy industry. Situating results of periodic national studies within the context of past and recent research provides an opportunity to gauge adoption of recommendations and best practices and to help identify persistent and new challenges that the industry is wrestling with to help guide research needs. Through this review of the 2 national studies, we identified several strengths of the Canadian and US dairy industries. In each area of calf health management, improvements relative to previous NAHMS studies and the published literature have been found in the level of mortality, amount of colostrum fed, housing, and the number of producers using pain control for disbudding and dehorning. There were, however, some areas that present clear opportunities for improvement. Specifically, although mortality levels have improved, a large number of calves die at birth, within the first 48 h of life, and during the preweaning period. To improve the health of calves in early life, producers could look at feeding high-quality colostrum at 10% of body weight in the first feeding, as well as feeding a larger amount of milk during the preweaning period. The barriers to making these management changes and improving overall calf health need to be identified in future studies. The majority of preweaning calves in Canada and the United States are housed in individual housing. This represents a clear opportunity for improvement because recent research has identified the positive aspects of group housing. Finally, with respect to pain control, improvements are needed (particularly in the United States) to ensure that pain management is provided when disbudding and dehorning calves. Although the science is clear on pain management, discussions with producers are needed to identify reasons for the lack of uptake.
Collapse
Affiliation(s)
- S Roche
- Department of Population Medicine, University of Guelph, Ontario, Canada N1G 2W1; ACER Consulting, Guelph, Ontario, Canada N1G 5L3
| | - D L Renaud
- Department of Population Medicine, University of Guelph, Ontario, Canada N1G 2W1
| | - C A Bauman
- Department of Population Medicine, University of Guelph, Ontario, Canada N1G 2W1
| | - J Lombard
- USDA-Animal and Plant Health Inspection Service-Veterinary Services, Field Epidemiological Investigation Services, Fort Collins, CO 80526-8117
| | - D Short
- USDA-Animal and Plant Health Inspection Service-Veterinary Services, Center for Epidemiology and Animal Health, National Animal Health Monitoring System, Fort Collins, CO 80526-8117
| | - J Saraceni
- ACER Consulting, Guelph, Ontario, Canada N1G 5L3
| | - D F Kelton
- Department of Population Medicine, University of Guelph, Ontario, Canada N1G 2W1.
| |
Collapse
|
4
|
Marmolejo Castaneda D, Morales-Barrera R, Suarez C, Lozano F, López Molina C, Gonzalez M, Mateo J, Carrion A, Mast R, Roche S, Semidey M, Navarro V, Serrano C, Valverde C, Trilla E, De Torres I, Raventos C, Carles J. Impact of maximal transurethral resection of bladder tumor before neoadjuvant chemotherapy for muscle-invasive bladder cancer. EUR UROL SUPPL 2022. [DOI: 10.1016/s2666-1683(22)02579-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022] Open
|
5
|
Seitzinger AH, Garner MG, Bradhurst R, Roche S, Breed AC, Capon T, Miller C, Tapsuwan S. FMD vaccine allocation and surveillance resourcing options for a potential Australian incursion. Aust Vet J 2022; 100:550-561. [PMID: 36106431 PMCID: PMC9826428 DOI: 10.1111/avj.13195] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2022] [Accepted: 06/11/2022] [Indexed: 01/18/2023]
Abstract
Australian Animal Disease Spread (AADIS) epidemiological simulation modelling of potential foot-and-mouth disease outbreaks in the state of Victoria, Australia examined the targeted use of limited vaccine supplies in combination with varying surveillance resources. Updated, detailed estimates of government response costs were prepared based on state level data inputs of required and available resources. Measures of outbreak spread such as duration and numbers of animals removed through depopulation of infected and vaccinated herds from the epidemiological modelling were compared to summed government response costs. This comparison illustrated the trade-offs between targeted control strategies combining vaccination-to-remove and varying surveillance capacities and their corresponding costs. For this intensive cattle and sheep producing region: (1) Targeting vaccination toward intensive production areas or toward specialized cattle operations had outbreak control and response cost advantages similar to vaccination of all species. The median duration was reduced by 27% and response costs by 11%. (2) Adding to the pool of outbreak surveillance resources available further decreased outbreak duration and outbreak response costs. The median duration was reduced by an additional 13% and response costs declined by an additional 8%. (3) Pooling of vaccine resources overcame the very early binding constraints under proportional allocation of vaccines to individual states with similar reductions in outbreak duration to those with additional surveillance resources. However, government costs rose substantially by over 40% and introduced additional risk of a negative consumer response. Increased knowledge of the outbreak situation obtained from more surveillance led to better-informed vaccination deployment decisions in the short timeframe they needed to be made.
Collapse
Affiliation(s)
- AH Seitzinger
- CSIRO Land and Water2 Clunies Ross StreetBlack MountainAustralian Capital Territory2601Australia
| | - MG Garner
- CSIRO Land and Water2 Clunies Ross StreetBlack MountainAustralian Capital Territory2601Australia
| | - R Bradhurst
- Centre of Excellence for Biosecurity Risk Analysis, School of BioSciencesUniversity of MelbourneParkvilleVictoria3010Australia
| | - S Roche
- Australian Government Department of Agriculture, Water and the EnvironmentCanberraAustralian Capital Territory2601Australia
| | - AC Breed
- Australian Government Department of Agriculture, Water and the EnvironmentCanberraAustralian Capital Territory2601Australia,School of Veterinary ScienceUniversity of QueenslandBrisbaneQueensland4067Australia
| | - T Capon
- CSIRO Land and Water2 Clunies Ross StreetBlack MountainAustralian Capital Territory2601Australia
| | - C Miller
- Australian Government Department of Agriculture, Water and the EnvironmentCanberraAustralian Capital Territory2601Australia
| | - S Tapsuwan
- CSIRO Land and Water2 Clunies Ross StreetBlack MountainAustralian Capital Territory2601Australia
| |
Collapse
|
6
|
Hook A, Randall JL, Grubb CM, Ellis N, Wellington J, Hemmad A, Zerdelis A, Winnett ARD, Geers BDW, Sykes B, Auty CN, Vinchenzo C, Thorburn CE, Asogbon D, Granger E, Boagey H, Raphael J, Patel K, Bhargava K, Dolley MKM, Maden MJ, Shah MM, Lee QM, Vaidya R, Sehdev S, Barai S, Roche S, Khalid U, Codling DA, Harrison JR. Anti-cholinergic drug burden in patients with dementia increases after hospital admission: a multicentre cross-sectional study. BMC Geriatr 2022; 22:783. [PMID: 36203156 PMCID: PMC9541078 DOI: 10.1186/s12877-022-03235-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/09/2021] [Accepted: 05/09/2022] [Indexed: 12/02/2022] Open
Abstract
Background Anticholinergic medications are drugs that block cholinergic transmission, either as their primary therapeutic action or as a secondary effect. Patients with dementia may be particularly sensitive to the central effects of anticholinergic drugs. Anticholinergics also antagonise the effects of the main dementia treatment, cholinesterase inhibitors. Our study aimed to investigate anticholinergic prescribing for dementia patients in UK acute hospitals before and after admission. Methods We included 352 patients with dementia from 17 UK hospital sites in 2019. They were all inpatients on surgical, medical or Care of the Elderly wards. Information about each patient’s medications were collected using a standardised form, and the anticholinergic drug burden of each patient was calculated with an evidence-based online calculator. Wilcoxon’s rank test was used to look at the correlation between two subgroups upon admission and discharge. Results On admission to hospital, 37.8% of patients had an anticholinergic burden score ≥ 1 and 5.68% ≥3. On discharge, 43.2% of patients with an anticholinergic burden score ≥ 1 and 9.1% ≥3. The increase in scores was statistically significant (p = 0.001). Psychotropics were the most common group of anticholinergic medications prescribed at discharge. Of those patients taking cholinesterase inhibitors, 44.9% were also prescribed anticholinergic medications. Conclusions Our cross-sectional, multicentre study found that people with dementia are commonly prescribed anticholinergic medications, even if concurrently taking cholinesterase inhibitors, and are significantly more likely to be discharged from hospital with a higher anticholinergic burden than on admission. Supplementary Information The online version contains supplementary material available at 10.1186/s12877-022-03235-9.
Collapse
Affiliation(s)
- Annabelle Hook
- Cardiff University School of Medicine, Neuadd Meirionnydd, Cardiff, CF14 4YS, UK. .,Great Western Hospital, Marlborough Road, Swindon, SN3 6BB, UK.
| | - Jessica L Randall
- Cardiff University School of Medicine, Neuadd Meirionnydd, Cardiff, CF14 4YS, UK
| | - Carla M Grubb
- Cardiff University School of Medicine, Neuadd Meirionnydd, Cardiff, CF14 4YS, UK.,Betsi Cadwaladr University Health Board, Bangor, LL57 2PW, UK
| | - Natalie Ellis
- Cardiff University School of Medicine, Neuadd Meirionnydd, Cardiff, CF14 4YS, UK.,Withybush Hospital, Fishguard Road, Haverfordwest, SA61 2PZ, UK
| | - Jack Wellington
- Cardiff University School of Medicine, Neuadd Meirionnydd, Cardiff, CF14 4YS, UK
| | - Aayushi Hemmad
- The Medical School, Newcastle University, Framlington Place, Newcastle upon Tyne, NE2 4HH, UK
| | - Agisilaos Zerdelis
- The James Cook University Hospital, Marton Road, Middlesbrough, TS4 3BW, UK.,University Hospital of Wales, Heath Park Way, Cardiff, CF14 4XW, UK
| | - Andrew R D Winnett
- Whipps Cross University Hospital, Whipps Cross Road, Leytonstone, London, EN11 1NR, UK
| | | | - Bethany Sykes
- University of Exeter Medical School, Heavitree Road, Exeter, EX1 2LU, UK
| | - Charlotte N Auty
- School of Medicine, University of Manchester, Manchester, M13 9PL, UK.,Queen's Medical Centre Nottingham, Clifton Boulevard, Derby Road, Nottingham, NG7 2UH, UK
| | - Cecilia Vinchenzo
- Lancaster Medical School, Faculty of Health and Medicine, Lancaster University, Furness Building, Lancaster, LA1 4YG, UK
| | - Christiane E Thorburn
- Bristol Medical School, University of Bristol, First Floor, 5 Tyndall Avenue, Bristol, BS8 1UD, UK
| | - Daniella Asogbon
- Birmingham Medical School, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK
| | - Emily Granger
- University Hospitals of Morecambe Bay NHS Foundation Trust, Burton Road, Kendal, LA9 7RG, UK.,Lancashire Teaching Hospitals NHS Foundation Trust, Sharoe Green Lane, Fulwood, Preston, Lancashire, PR2 9HT, UK
| | - Heather Boagey
- Medical Sciences Division, University of Oxford, John Radcliffe Hospital, Headley Way, Oxford, OX3 9DU, UK
| | - Juliet Raphael
- Norwich Medical School, University of East Anglia, Norwich Research Park, Norwich, Norfolk, NR4 7TJ, UK
| | - Kajal Patel
- School of Medicine, University of Manchester, Manchester, M13 9PL, UK
| | - Kartik Bhargava
- The Medical School, Newcastle University, Framlington Place, Newcastle upon Tyne, NE2 4HH, UK
| | - Mary-Kate M Dolley
- Peninsula Medical School, The Faculty of Medicine and Dentistry, The John Bull Building, Plymouth Science Park, Research Way, Plymouth, PL6 8BU, UK
| | - Matthew J Maden
- School of Medicine, University of Manchester, Manchester, M13 9PL, UK
| | - Mehdin M Shah
- Bart's and The London School of Medicine and Dentistry, Queen Mary's University of London, Garrod Building, Turner Street, Whitechapel, London, E1 2AD, UK
| | - Qao M Lee
- Bart's and The London School of Medicine and Dentistry, Queen Mary's University of London, Garrod Building, Turner Street, Whitechapel, London, E1 2AD, UK
| | - Ratnaraj Vaidya
- The Medical School, Newcastle University, Framlington Place, Newcastle upon Tyne, NE2 4HH, UK
| | - Simran Sehdev
- Faculty of Medicine, University of Southampton, Building 85, Life Sciences Building, Highfield Campus, Southampton, SO17 1BJ, UK
| | - Sneha Barai
- School of Clinical Medicine, University of Cambridge, Box 111, Cambridge Biomedical Campus, Cambridge, CB2 0SP, UK.,Peterborough City Hospital, Edith Cavell Campus, Bretton Gate, Peterborough, PE3 9GZ, UK
| | - Sophie Roche
- Medical Sciences Division, University of Oxford, John Radcliffe Hospital, Headley Way, Oxford, OX3 9DU, UK
| | - Uzair Khalid
- University College London Medical School, 74 Huntley St, Bloomsbury, London, WC1E 6DE, UK.,St George's Hospital, Blackshaw Road, Tooting, London, SW17 0QT, UK
| | - David A Codling
- King's College London, Institute of Psychiatry, Psychology and Neuroscience, 16 De Crespigny Park, London, SE5 8AF, UK
| | - Judith R Harrison
- Biomedical Research Building Campus for Ageing and Vitality, Newcastle University, Newcastle upon Tyne, NE4 5PL, UK.,Cardiff University Brain Research Imaging Centre (CUBRIC), Cardiff University, Maindy Road, Cardiff, CF24 4HQ, UK
| |
Collapse
|
7
|
Conlon N, Roche S, O’Neill F, Meiller J, Browne A, Breen L, O’Driscoll L, Cremona M, Hennessy B, Crown J, Collins D. Neratinib plus dasatinib has pre-clinical efficacy against HER2-positive breast cancer. Eur J Cancer 2022. [DOI: 10.1016/s0959-8049(22)00974-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
8
|
Triquell Llaurado M, Regis L, Salazar A, Planas J, Celma A, Cuadras M, Roche S, Mast R, Morote J, Trilla E. The position of urethrovesical anastomosis after robotic radical prostatectomy assessed by MRI predicts early functional recovery: A cohort analyses from a randomized clinical trial. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)01211-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
9
|
Hodgson SH, Iveson P, Larwood J, Roche S, Morrison H, Cosgrove C, Galiza E, Ikram S, Lemm N, Mehdipour S, Owens D, Pacurar M, Schumacher M, Shaw RH, Faust SN, Heath PT, Pollard AJ, Emary KRW, Pollock KM, Lazarus R. Incidental findings in UK healthy volunteers screened for a COVID-19 vaccine trial. Clin Transl Sci 2022; 15:524-534. [PMID: 34670021 PMCID: PMC8652599 DOI: 10.1111/cts.13170] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2021] [Revised: 08/29/2021] [Accepted: 09/13/2021] [Indexed: 11/29/2022] Open
Abstract
The safety of novel therapeutics and vaccines are typically assessed in early phase clinical trials involving "healthy volunteers." Abnormalities in such individuals can be difficult to interpret and may indicate previously unrecognized medical conditions. The frequency of incidental findings (IFs) in healthy volunteers who attend for clinical trial screening is unclear. To assess this, we retrospectively analyzed data for 1838 "healthy volunteers" screened for enrolment in a UK multicenter, phase I/II severe acute respiratory syndrome-coronavirus 2 (SARS-COV-2) vaccine trial. Participants were predominantly White (89.7%, 1640/1828) with a median age of 34 years (interquartile range [IQR] = 27-44). There were 27.7% of participants (510/1838) who had at least one IF detected. The likelihood of identifying evidence of a potential, new blood-borne virus infection was low (1 in 238 participants) compared with identification of an elevated alanine transaminase (ALT; 1 in 17 participants). A large proportion of participants described social habits that could impact negatively on their health; 21% consumed alcohol in excess, 10% were current smokers, 11% described recreational drug use, and only 48% had body weight in the ideal range. Our data demonstrate that screening prior to enrollment in early phase clinical trials identifies a range of IFs, which should inform discussion during the consent process. Greater clarity is needed to ensure an appropriate balance is struck between early identification of medical problems and avoidance of exclusion of volunteers due to spurious or physiological abnormalities. Debate should inform the role of the trial physician in highlighting and advising about unhealthy social habits.
Collapse
Affiliation(s)
- Susanne H. Hodgson
- Centre for Clinical Vaccinology and Tropical MedicineThe Jenner InstituteUniversity of OxfordOxfordUK
| | - Poppy Iveson
- The University of Oxford Clinical Medical SchoolUniversity of OxfordOxfordUK
| | - Jessica Larwood
- The University of Oxford Clinical Medical SchoolUniversity of OxfordOxfordUK
| | - Sophie Roche
- The University of Oxford Clinical Medical SchoolUniversity of OxfordOxfordUK
| | - Hazel Morrison
- Centre for Clinical Vaccinology and Tropical MedicineThe Jenner InstituteUniversity of OxfordOxfordUK
| | | | - Eva Galiza
- Vaccine InstituteSt George’s University of LondonLondonUK
| | - Sabina Ikram
- Vaccine InstituteSt George’s University of LondonLondonUK
| | | | | | - Daniel Owens
- NIHR Southampton Clinical Research Facility and NIHR Southampton Biomedical Research CentreUniversity Hospital Southampton NHS Foundation TrustFaculty of Medicine and Institute for Life SciencesUniversity of SouthamptonSouthamptonUK
| | - Mihaela Pacurar
- NIHR Southampton Clinical Research Facility and NIHR Southampton Biomedical Research CentreUniversity Hospital Southampton NHS Foundation TrustFaculty of Medicine and Institute for Life SciencesUniversity of SouthamptonSouthamptonUK
| | | | - Robert H. Shaw
- Oxford Vaccine GroupDepartment of PaediatricsCentre for Clinical Vaccinology and Tropical MedicineNIHR Oxford Biomedical Research CentreUniversity of OxfordOxfordUK
| | - Saul N. Faust
- NIHR Southampton Clinical Research Facility and NIHR Southampton Biomedical Research CentreUniversity Hospital Southampton NHS Foundation TrustFaculty of Medicine and Institute for Life SciencesUniversity of SouthamptonSouthamptonUK
| | - Paul T. Heath
- Vaccine InstituteSt George’s University of LondonLondonUK
| | - Andrew J. Pollard
- Oxford Vaccine GroupDepartment of PaediatricsCentre for Clinical Vaccinology and Tropical MedicineNIHR Oxford Biomedical Research CentreUniversity of OxfordOxfordUK
| | - Katherine R. W. Emary
- Oxford Vaccine GroupDepartment of PaediatricsCentre for Clinical Vaccinology and Tropical MedicineNIHR Oxford Biomedical Research CentreUniversity of OxfordOxfordUK
| | | | - Rajeka Lazarus
- University Hospitals Bristol and Weston NHS Foundation TrustBristolUK
| |
Collapse
|
10
|
Chivers D, Lambrechts A, Vrettos B, Dachs R, Roche S. Unrepaired rotator cuff tears following acromioplasty. SA orthop j 2022. [DOI: 10.17159/2309-8309/2019/v18n3a5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
|
11
|
Rachuene A, Dey R, de Villiers S, Berry K, Mulder M, du Plessis J, Roche S. Retrospective audit of serum vitamin D levels in patients who underwent Latarjet procedure for anterior shoulder instability. SA orthop j 2022. [DOI: 10.17159/2309-8309/2022/v21n4a4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022] Open
Abstract
BACKGROUND: The aim of this study was to review vitamin D levels in patients who underwent Latarjet procedures at a tertiary teaching hospital and a private clinic. METHODS: A retrospective review of clinical and radiological records was performed for 22 patients who underwent Latarjet procedure between November 2017 and June 2019. Postoperative vitamin D levels were retrieved and classified into sufficient (> 75 nmol/L), insufficient (25-75 nmol/L), and deficient (< 25 nmol/L) groups. Two observers assessed radiographic images of the patients at six weeks and three months after surgery. Any bone resorption, fracture and nonunion were reported, and interobserver reliability was analysed using the intraclass correlation coefficient (ICC). RESULTS: The median age was 20.5 years and was predominantly male. A little more than two-thirds (68.1%) of the patients were found to have insufficient or deficient levels of vitamin D. One patient from the insufficient group had postoperative bone resorption. Good interobserver reliability was observed with the ICC value being 0.86. CONCLUSION: This study found a prevalence of insufficient/deficient vitamin D levels in young patients undergoing a Latarjet procedure. This study serves as a reminder to orthopaedic surgeons that vitamin D deficiency is prevalent among patients undergoing Latarjet Level of evidence: Level 4.
Collapse
|
12
|
Kauta N, du Plessis J, de Wet J, Vrettos B, Roche S. Current concepts on the assessment of a patient with a traumatic anterior shoulder dislocation. SA orthop j 2022. [DOI: 10.17159/2309-8309/2022/v21n2a6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
Abstract
Anterior shoulder dislocation is a common condition that most orthopaedic surgeons will have to deal with in their practice. Nonoperative management of the initial traumatic anterior shoulder dislocation is likely to lead to a recurrent shoulder dislocation in more than 90% of cases in the younger active population. Recurrent anterior shoulder dislocation can persist even after instability surgery in certain cases. A detailed, accurate assessment of the patient is of paramount importance for successful treatment. This review aims to provide insight into key concepts to consider in the assessment of an anterior shoulder dislocation. Predisposing factors, clinical examination and the role of imaging in the assessment of an anterior shoulder dislocation will be reviewed. Level of evidence: Level 5
Collapse
|
13
|
Prouvot J, Pambrun E, Antoine V, Couchoud C, Vigneau C, Roche S, Francois M, Mariat C, Babici D, Prelipcean C, Moranne O. Low performance of prognostic tools for predicting death before dialysis in older patients with advanced CKD. J Nephrol 2021; 35:993-1004. [PMID: 34787796 DOI: 10.1007/s40620-021-01180-1] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/04/2021] [Accepted: 10/06/2021] [Indexed: 12/14/2022]
Abstract
INTRODUCTION Chronic kidney disease (CKD) is a disease which is spreading worldwide, especially among older patients. Several prognostic scores have been developed to predict death in older CKD patients, but they have not been validated. We aimed to evaluate the existing risk scores for predicting death before dialysis start, identified via an in-depth review, in a cohort of elderly patients with advanced CKD. METHODS We performed a review to identify scores predicting death, developed in and applicable to CKD patients. Each score was evaluated with an absolute risk calculation from the patients' baseline characteristics. We used a French prospective multicentre cohort of elderly patients (> 75 years) with advanced CKD [estimated glomerular filtration rate (eGFR) < 20 mL/min/1.73 m2], recruited from nephrological centres, with a 5-year follow-up. The outcome considered was death before initiating dialysis. Discrimination [area under curve (AUC)], calibration and Brier score were calculated for each score at its time frame. RESULTS Our review found 6 equations predicting death before dialysis in CKD patients. Four of these (GOLDFARB, BANSAL, GRAMS 2 and 4 years) were evaluated. The validation cohort (Parcours de Soins des Personnes Âgées Parcours de Soins des Personnes Âgées, PSPA) included 573 patients, with a median age of 82 years and a median eGFR of 13 mL/min/1.73 m2. At the end of follow-up, 287 (50%) patients had started dialysis and 238 (41%) patients had died before dialysis. The four equations evaluated showed average discrimination (AUC 0.61-0.70) and, concerning calibration, a global overestimation of the risk of death. DISCUSSION The available scores predicting death before dialysis showed low performance among older patients with advanced CKD in a French multicentre cohort, indicating the need to upgrade them or develop new scores for this population.
Collapse
Affiliation(s)
- Julien Prouvot
- IDESP, INSERM Université de Montpellier, Montpellier, France
- Service Néphrologie-Dialyses-Aphérèses, Hôpital Universitaire de Nîmes, CHU Caremeau, Place du Pr Debré, 30000, Nimes, France
| | - Emilie Pambrun
- Service Néphrologie-Dialyses-Aphérèses, Hôpital Universitaire de Nîmes, CHU Caremeau, Place du Pr Debré, 30000, Nimes, France
| | - Valery Antoine
- IDESP, INSERM Université de Montpellier, Montpellier, France
- Service de Gériatrie, Hôpital Universitaire de Nîmes, Nimes, France
| | - Cecile Couchoud
- Registre REIN, Agence de la Biomedecine, Saint-Denis La Plaine, France
- CNRS, UMR 5558, Laboratoire de Biométrie et Biologie Evolutive, Equipe Biostatistique Santé, Villeurbanne, France
| | - Cecile Vigneau
- CHU Pontchaillou, Service de Néphrologie-Dialyse-Transplantation, Université Rennes 1, IRSET, Rennes, France
| | - Sophie Roche
- Service de Nephrologie‑Dialyse, CH Macon, Macon, France
| | - Maud Francois
- Service de Néphrologie-Dialyse-Transplantation, CHU Tours, Tours, France
| | - Christophe Mariat
- Service de Néphrologie, Hôpital Nord, Centre Hospitalier Universitaire de Saint-Étienne, 42055, Saint-Étienne Cedex 02, France
| | - Daniela Babici
- Service Néphrologie-Dialyse, GHR MSA, Hôpital Emile Muller, Mulhouse, France
| | - Camelia Prelipcean
- Service Néphrologie-Dialyses-Aphérèses, Hôpital Universitaire de Nîmes, CHU Caremeau, Place du Pr Debré, 30000, Nimes, France
| | - Olivier Moranne
- IDESP, INSERM Université de Montpellier, Montpellier, France.
- Service Néphrologie-Dialyses-Aphérèses, Hôpital Universitaire de Nîmes, CHU Caremeau, Place du Pr Debré, 30000, Nimes, France.
| |
Collapse
|
14
|
Roche S, Bandyopadhyay S, Grassam-Rowe A, Brown RA, Iveson P, Mallett G, Eggington H, Swales C. Cross-sectional Survey of Medical student Attitudes to Research and Training pathways (SMART) in the UK: study protocol. BMJ Open 2021; 11:e050104. [PMID: 34475177 PMCID: PMC8413964 DOI: 10.1136/bmjopen-2021-050104] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
BACKGROUND An understanding and appreciation of scientific research is a key quality of the modern clinician. Yet the Medical Schools Council has previously reported a reduction in the number of clinicians performing research. To explore the reasons for this difficulty, this multicentre, cross-sectional study aims to determine the medical student involvement and perceptions of research and research-orientated careers. It will additionally identify perceived barriers and incentives to participating in research as a student. METHODS AND ANALYSIS This cross-sectional study of medical students at UK medical schools recognised by the General Medical Council will be administered using an online questionnaire. This will be disseminated nationally over a 2-month period through collaborative university medical school and student networks. The primary outcome is to determine the extent to which medical students are currently involved in research. Secondary outcomes include identifying the personal and demographic factors involved in incentivising and deterring medical students from becoming involved in research during medical school. This will be achieved using a selection of Likert scale, multiple-choice and free text questions. Ordinal logistic regression analysis will be performed to understand the association between specific factors and student involvement in research. This study will also characterise the proportion of medical students who are currently interested in conducting research in the future. ETHICS AND DISSEMINATION Ethics approval has been obtained from the Medical Sciences Interdivisional Research Ethics Committee, Oxford, England. The results will be disseminated via publication in a peer-reviewed medical journal and may be presented at local, regional, national and international conferences by medical student collaborators.
Collapse
Affiliation(s)
- Sophie Roche
- Medical Sciences Division, University of Oxford, Oxford, UK
| | | | | | | | - Poppy Iveson
- Medical Sciences Division, University of Oxford, Oxford, UK
| | - Garry Mallett
- Medical Sciences Division, University of Oxford, Oxford, UK
| | | | | |
Collapse
|
15
|
Schwartzmann I, Celma A, Regis L, Planas J, Roche S, de Torres IM, Semidey ME, Morote J. The current value of histological findings in negative prostate biopsies to predict the future risk of clinically significant prostate cancer. Actas Urol Esp 2021; 45:447-454. [PMID: 34140257 DOI: 10.1016/j.acuroe.2020.09.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2020] [Accepted: 09/22/2020] [Indexed: 11/29/2022]
Abstract
BACKGROUND Repeat prostate biopsy (PBx) is recommended under persistent suspicion of prostate cancer (PCa) or in the face of the following findings: atypical small acinar proliferation (ASAP); extense (≥3 biopsy sites) high-grade prostatic intraepithelial neoplasia (HGPIN); or HGPIN with atypical glands; suspicious for adenocarcinoma (PIN-ATYP). Nowadays; multiparametric magnetic resonance imaging (mpMRI) and mpMRI targeted PBx (MRI-TBx) are recommended in repeat PBx. Our objective was to analyze the current value of ASAP; mHGPIN; PIN-ATYP and other histological findings to predict clinically significant PCa (csPCa) risk. METHODS Retrospective analysis of 377 repeat PBxs. MRI-TBx was performed when Prostate Imaging-Reporting and Data System (PI-RADS) score >3 and 12-core transrectal ultrasound (TRUS) systematic PBx when ≤2. ASAP; HGPIN; mHGPIN; PIN-ATYP; and 8 other histological findings were prospectively reported in negative PBx. CsPCa was defined as ISUP group grade >2. RESULTS Incidence of ASAP; multifocal HGPIN (mHGPIN) and PINATYP was 4.2%; 39.7% and 3.7% respectively; and csPCa rate was statistically similar among men with these histological findings. However; the rate of csPCa was 22.2% when proliferative inflammatory atrophy (PIA) was present; and 36.1% when it was not. PIA was the only histological finding which predicted lower risk of csPCa; with an OR of 0.54 (95%CI: 0.308-0.945; P = .031). In addition; PIA was an independent predictor of a model combining clinical variables and mpMRI which reached area under de ROC curve of 0.86 (95%CI: 0.83-0.90). CONCLUSION PIA emerged as the only predictive histological finding of csPCa risk and can contribute to a predictive model. mHGPIN failed to predict csPCa risk. The low incidence of ASAP (4.2%) and PIN-ATYP (3.7%) prevented us from drawing conclusions.
Collapse
Affiliation(s)
- I Schwartzmann
- Departamento de Urología y Trasplante Renal, Hospital Universitario Vall d'Hebrón, Universidad Autónoma de Barcelona, Barcelona, Spain.
| | - A Celma
- Departamento de Urología y Trasplante Renal, Hospital Universitario Vall d'Hebrón, Universidad Autónoma de Barcelona, Barcelona, Spain
| | - L Regis
- Departamento de Urología y Trasplante Renal, Hospital Universitario Vall d'Hebrón, Universidad Autónoma de Barcelona, Barcelona, Spain
| | - J Planas
- Departamento de Urología y Trasplante Renal, Hospital Universitario Vall d'Hebrón, Universidad Autónoma de Barcelona, Barcelona, Spain
| | - S Roche
- Departamento de Radiología, Hospital Universitario Vall d'Hebrón, Univerisad Autónoma de Barcelona, Barcelona, Spain
| | - I M de Torres
- Departamento de Patología, Hospital Universitario Vall d'Hebrón Universidad Autónoma de Barcelona, Barcelona, Spain; Universidad Autónoma de Barcelona, Barcelona, Spain
| | - M E Semidey
- Departamento de Patología, Hospital Universitario Vall d'Hebrón Universidad Autónoma de Barcelona, Barcelona, Spain
| | - J Morote
- Departamento de Urología y Trasplante Renal, Hospital Universitario Vall d'Hebrón, Universidad Autónoma de Barcelona, Barcelona, Spain; Universidad Autónoma de Barcelona, Barcelona, Spain
| |
Collapse
|
16
|
Morote J, Triquell M, Borque A, Esteban L, Celma A, Roche S, De Torres I, Mast R, Semidey M, Regis L, Santamaría A, Abascal J, Solà C, Servián P, Salvador D, Planas J, Trilla E. A predictive tool for clinically significant prostate cancer detection in men with prostate cancer suspicion. Eur Urol 2021. [DOI: 10.1016/s0302-2838(21)01280-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
17
|
Merviel P, Bouée S, Jacamon AS, Chabaud JJ, Le Martelot MT, Roche S, Rince C, Drapier H, Perrin A, Beauvillard D. Progesterone levels on the human chorionic gonadotropin trigger day affect the pregnancy rates for embryos transferred at different stages of development in both general and selected IVF/ICSI populations. BMC Pregnancy Childbirth 2021; 21:363. [PMID: 33957886 PMCID: PMC8101180 DOI: 10.1186/s12884-021-03832-3] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/16/2020] [Accepted: 04/26/2021] [Indexed: 11/13/2022] Open
Abstract
Background Two meta-analyses have shown that pregnancy and birth rates are significantly higher after blastocyst transfer than after cleaved embryo transfer. Other studies have revealed that a serum progesterone level > 1.5 ng/ml on the trigger day is responsible for premature luteinization and is associated with a low pregnancy rate. The objectives of this retrospective study were to determine whether blastocyst transfer gave higher pregnancy rates than cleaved embryo transfer at day 3 in both the general and selected IVF/ICSI populations, and whether the serum progesterone level influenced the pregnancy rate. Method We studied IVF/ICSI cycles with GnRH antagonist - FSH/hMG protocols in a general population (n = 1210) and a selected “top cycle” population (n = 677), after blastocyst transfer on day 5 or cleaved embryo transfer on day 3. The selected couples had to meet the following criteria: female age < 35, first or second cycle, and one or two embryos transferred. We recorded predictive factors for pregnancy and calculated the progesterone to oocyte index (POI), the progesterone:estradiol ratio (P:E2 ratio), and the progesterone to follicle (> 14 mm) index (PFI). Results In the general population, the clinical pregnancy rate was significantly higher after blastocyst transfer (33.3%) than after cleaved embryo transfer (25.3%; p < 0.01); the same was true for the birth rate (32.1 and 22.8%, respectively, p < 0.01). The differences between blastocyst and embryo transfer groups were not significant in the selected population (respectively 35.7% vs. 35.8% for the clinical pregnancy rate, and 33.9 and 34.9% for the birth rate). The serum progesterone levels on the eve of the trigger day and on the day itself were significantly lower in the pregnant women (p < 0.01). We found a serum progesterone threshold of 0.9 ng/ml, as also reported by other researchers. The POI and the PFI appear to have predictive value for cleaved embryos transfers. Conclusions Blastocyst transfers were associated with higher clinical pregnancy and birth rates than cleaved embryo transfers in a general population but not in a selected population. The serum progesterone levels on the eve of the trigger day and on the day itself predicted the likelihood of pregnancy.
Collapse
Affiliation(s)
- P Merviel
- Department of Gynecology, Obstetrics and Reproductive Medicine, Brest University Hospital, 2 avenue Foch, F-29200, Brest, France.
| | - S Bouée
- Department of Gynecology, Obstetrics and Reproductive Medicine, Brest University Hospital, 2 avenue Foch, F-29200, Brest, France
| | - A S Jacamon
- Department of Gynecology, Obstetrics and Reproductive Medicine, Brest University Hospital, 2 avenue Foch, F-29200, Brest, France
| | - J J Chabaud
- Department of Gynecology, Obstetrics and Reproductive Medicine, Brest University Hospital, 2 avenue Foch, F-29200, Brest, France
| | - M T Le Martelot
- Department of Gynecology, Obstetrics and Reproductive Medicine, Brest University Hospital, 2 avenue Foch, F-29200, Brest, France
| | - S Roche
- Department of Gynecology, Obstetrics and Reproductive Medicine, Brest University Hospital, 2 avenue Foch, F-29200, Brest, France
| | - C Rince
- Department of Gynecology, Obstetrics and Reproductive Medicine, Brest University Hospital, 2 avenue Foch, F-29200, Brest, France
| | - H Drapier
- Department of Gynecology, Obstetrics and Reproductive Medicine, Brest University Hospital, 2 avenue Foch, F-29200, Brest, France
| | - A Perrin
- Department of Gynecology, Obstetrics and Reproductive Medicine, Brest University Hospital, 2 avenue Foch, F-29200, Brest, France
| | - D Beauvillard
- Department of Gynecology, Obstetrics and Reproductive Medicine, Brest University Hospital, 2 avenue Foch, F-29200, Brest, France
| |
Collapse
|
18
|
Randall J, Hook A, Grubb CM, Ellis N, Wellington J, Hemmad A, Zerdelis A, Geers B, Sykes B, Auty C, Vinchenzo C, Thorburn C, Asogbon D, Granger E, Boagey H, Raphael J, Patel K, Bhargava K, Dolley MK, Maden M, Shah M, Lee Q, Vaidya R, Sehdev S, Barai S, Roche S, Khalid U, Harrison J, Codling D. Dementia patients have greater anti-cholinergic drug burden on discharge from hospital: A multicentre cross-sectional study. Eur Psychiatry 2021. [PMCID: PMC9476103 DOI: 10.1192/j.eurpsy.2021.1127] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
IntroductionAnticholinergic medications block cholinergic transmission. The central effects of anticholinergic drugs can be particularly marked in patients with dementia. Furthermore, anticholinergics antagonise the effects of cholinesterase inhibitors, the main dementia treatment.ObjectivesThis study aimed to assess anticholinergic drug prescribing among dementia patients before and after admission to UK acute hospitals.Methods352 patients with dementia were included from 17 hospitals in the UK. All were admitted to surgical, medical or Care of the Elderly wards in 2019. Information about patients’ prescriptions were recorded on a standardised form. An evidence-based online calculator was used to calculate the anticholinergic drug burden of each patient. The correlation between two subgroups upon admission and discharge was tested with Spearman’s Rank Correlation.ResultsTable 1 shows patient demographics. On admission, 37.8% of patients had an anticholinergic burden score ≥1 and 5.68% ≥3. At discharge, 43.2% of patients had an anticholinergic burden score ≥1 and 9.1% ≥3. The increase was statistically significant (rho 0.688; p=2.2x10-16). The most common group of anticholinergic medications prescribed at discharge were psychotropics (see Figure 1). Among patients prescribed cholinesterase inhibitors, 44.9% were also taking anticholinergic medications.ConclusionsThis multicentre cross-sectional study found that people with dementia are frequently prescribed anticholinergic drugs, even if also taking cholinesterase inhibitors, and are significantly more likely to be discharged with a higher anticholinergic drug burden than on admission to hospital.Conflict of interestThis project was planned and executed by the authors on behalf of SPARC (Student Psychiatry Audit and Research Collaborative). We thank the National Student Association of Medical Research for allowing us use of the Enketo platform. Judith Harrison was su
Collapse
|
19
|
Touil N, Curie A, Reymond MP, Subtil F, Roche S, Gaillard S, Kassai B, Portes VD. Role of multidimensional evaluations in the support of school trajectories of children with mild to moderate intellectual disability. Eur Psychiatry 2021. [PMCID: PMC9470458 DOI: 10.1192/j.eurpsy.2021.352] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
Abstract
Introduction There is a lack of objective evaluation with validated tools in school children with intellectual disability (ID). Standardized and validated tools, allowing children evaluations and follow-up, exist but are poorly used. Our action-study wishes to develop evaluation practices to better adapt to the specific needs of children with ID. Objectives We evaluated the multidimensional profiles (cognitive, adaptative and behavioral) of children with ID attending regular or adapted school system. Methods School children, aged 5 to 13 years old, with mild to moderate ID were enrolled in this French cohort study. The multidimensional evaluation consisted of a school evaluation grid proposed by the French educational system, a scale of school needs (GEVA-sco), an intellectual assessment (WISC IV), a behavior adaptative scale (Vineland II) and a behavior rating scale (the French Nisonger Child Behavior Rating Form (Nisonger CBRF)). The results of this multidimensional assessment were analyzed. Results Between November 2014 and June 2016, 121 children were enrolled, 3 children were lost to follow-up. Analysis was performed on 118 children. Seventy one (60.2 %) were male. Fifty-two (44.1%) were aged 6 to 9 years. Sixty-eight (57.6%) children were in regular schools and 50 (42.4%) in adapted schools. Children in regular schools had a higher mean IQ score (57.5) than children in adapted schools (43.5). The adaptative behavior profile of children in regular school is less severe than in children in adapted schools. Conclusions Multidimensional evaluations allow optimizing and personalizing support. Evaluation of adaptative behavior is more informative than cognitive profile which does not differentiate between children skills Disclosure No significant relationships.
Collapse
|
20
|
Prouvot J, Pambrun E, Couchoud C, Vigneau C, Roche S, Allot V, Potier J, Francois M, Babici D, Prelipcean C, Moranne O. Low performance of prognostic tools for predicting dialysis in elderly people with advanced CKD. J Nephrol 2021; 34:1201-1213. [PMID: 33394346 DOI: 10.1007/s40620-020-00919-6] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2020] [Accepted: 11/13/2020] [Indexed: 12/23/2022]
Abstract
INTRODUCTION Clinical decision-making about care plans can be difficult for very elderly people with advanced chronic kidney disease (CKD). Current guidelines propose the use of prognostic tools predicting end stage renal disease (ESRD) to assist in a patient-centered shared decision-making approach. Our objective was to evaluate the existing risk model scores predicting ESRD, from data collected for a French prospective multicenter cohort of mainly octogenarians with advanced CKD. METHODS We performed a rapid review to identify the risk model scores predicting ESRD developed from CKD patient cohorts and evaluated them with data from a prospective multicenter French cohort of elderly (> 75 years) patients with advanced CKD (estimated glomerular filtration rate [eGFR] < 20 mL/min/1.75m2), followed up for 5 years. We evaluated these scores (in absolute risk) for discrimination, calibration and the Brier score. For scores using the same time frame, we made a joint calibration curve and compared areas under the curve (AUCs). RESULTS The PSPA cohort included 573 patients; their mean age was 83 years and their median eGFR was 13 mL/min/1.73 m2. At the end of follow-up, 414 had died and 287 had started renal replacement therapy (RRT). Our rapid review found 12 scores that predicted renal replacement therapy. Five were evaluated: the TANGRI 4-variable, DRAWZ, MARKS, GRAMS, and LANDRAY scores. No score performed well in the PSPA cohort: AUCs ranged from 0.57 to 0.65, and Briers scores from 0.18 to 0.25. CONCLUSIONS The low predictiveness for ESRD of the scores tested in a cohort of octogenarian patients with advanced CKD underlines the need to develop new tools for this population.
Collapse
Affiliation(s)
- Julien Prouvot
- EA2415, Université de Montpellier, Montpellier, France.,Service de Nephrologie, Dialyse et Apherese, Hôpital Universitaire de Caremeau, Nimes, France
| | - Emilie Pambrun
- Service de Nephrologie, Dialyse et Apherese, Hôpital Universitaire de Caremeau, Nimes, France
| | - Cecile Couchoud
- Registre REIN, Agence de la Biomedecine, Saint-Denis La Plaine, France.,CNRS, UMR 5558, Laboratoire de Biométrie et Biologie Evolutive, Equipe Biostatistique Santé, Villeurbanne, France
| | - Cecile Vigneau
- CHU Pontchaillou, Service de Néphrologie-Dialyse-Transplantation, Université Rennes 1, IRSET 1085, Rennes, France
| | - Sophie Roche
- Service de Néphrologie-Dialyse, CH Macon, Macon, France
| | - Vincent Allot
- CHU Limoges, Service de Néphrologie, Dialyse, Transplantation, Limoges, France
| | - Jerome Potier
- Service de Néphrologie-Dialyse, CH St Brieuc, Saint Brieuc, France
| | - Maud Francois
- CHU Tours, Service de Néphrologie-Dialyse-Transplantation, Tours, France
| | - Daniela Babici
- Hôpital Emile Muller, Service Néphrologie-Dialyse, GHR MSA, Mulhouse, France
| | - Camelia Prelipcean
- Service de Nephrologie, Dialyse et Apherese, Hôpital Universitaire de Caremeau, Nimes, France
| | - Olivier Moranne
- EA2415, Université de Montpellier, Montpellier, France. .,Service de Nephrologie, Dialyse et Apherese, Hôpital Universitaire de Caremeau, Nimes, France.
| | | |
Collapse
|
21
|
Bandyopadhyay S, Baticulon RE, Kadhum M, Alser M, Ojuka DK, Badereddin Y, Kamath A, Parepalli SA, Brown G, Iharchane S, Gandino S, Markovic-Obiago Z, Scott S, Manirambona E, Machhada A, Aggarwal A, Benazaize L, Ibrahim M, Kim D, Tol I, Taylor EH, Knighton A, Bbaale D, Jasim D, Alghoul H, Reddy H, Abuelgasim H, Saini K, Sigler A, Abuelgasim L, Moran-Romero M, Kumarendran M, Jamie NA, Ali O, Sudarshan R, Dean R, Kissyova R, Kelzang S, Roche S, Ahsan T, Mohamed Y, Dube AM, Gwini GP, Gwokyala R, Brown R, Papon MRKK, Li Z, Ruzats SS, Charuvila S, Peter N, Khalidy K, Moyo N, Alser O, Solano A, Robles-Perez E, Tariq A, Gaddah M, Kolovos S, Muchemwa FC, Saleh A, Gosman A, Pinedo-Villanueva R, Jani A, Khundkar R. Infection and mortality of healthcare workers worldwide from COVID-19: a systematic review. BMJ Glob Health 2020; 5:e003097. [PMID: 33277297 PMCID: PMC7722361 DOI: 10.1136/bmjgh-2020-003097] [Citation(s) in RCA: 340] [Impact Index Per Article: 85.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2020] [Revised: 09/19/2020] [Accepted: 10/09/2020] [Indexed: 12/18/2022] Open
Abstract
OBJECTIVES To estimate COVID-19 infections and deaths in healthcare workers (HCWs) from a global perspective during the early phases of the pandemic. DESIGN Systematic review. METHODS Two parallel searches of academic bibliographic databases and grey literature were undertaken until 8 May 2020. Governments were also contacted for further information where possible. There were no restrictions on language, information sources used, publication status and types of sources of evidence. The AACODS checklist or the National Institutes of Health study quality assessment tools were used to appraise each source of evidence. OUTCOME MEASURES Publication characteristics, country-specific data points, COVID-19-specific data, demographics of affected HCWs and public health measures employed. RESULTS A total of 152 888 infections and 1413 deaths were reported. Infections were mainly in women (71.6%, n=14 058) and nurses (38.6%, n=10 706), but deaths were mainly in men (70.8%, n=550) and doctors (51.4%, n=525). Limited data suggested that general practitioners and mental health nurses were the highest risk specialities for deaths. There were 37.2 deaths reported per 100 infections for HCWs aged over 70 years. Europe had the highest absolute numbers of reported infections (119 628) and deaths (712), but the Eastern Mediterranean region had the highest number of reported deaths per 100 infections (5.7). CONCLUSIONS COVID-19 infections and deaths among HCWs follow that of the general population around the world. The reasons for gender and specialty differences require further exploration, as do the low rates reported in Africa and India. Although physicians working in certain specialities may be considered high risk due to exposure to oronasal secretions, the risk to other specialities must not be underestimated. Elderly HCWs may require assigning to less risky settings such as telemedicine or administrative positions. Our pragmatic approach provides general trends, and highlights the need for universal guidelines for testing and reporting of infections in HCWs.
Collapse
Affiliation(s)
- Soham Bandyopadhyay
- Oxford University Global Surgery Group, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, Oxfordshire, UK
| | - Ronnie E Baticulon
- Philippine General Hospital, University of the Philippines Manila College of Medicine, Manila, Metro Manila, The Philippines
| | - Murtaza Kadhum
- Oxford University Global Surgery Group, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, Oxfordshire, UK
| | - Muath Alser
- Kasr Al Ainy School of Medicine, Cairo University Kasr Alainy Faculty of Medicine, Cairo, Egypt
| | - Daniel K Ojuka
- Department of Surgery, University of Nairobi College of Health Sciences, Nairobi, Kenya
| | - Yara Badereddin
- Faculty of Pharmacy, Al Azhar University-Gaza, Gaza, State of Palestine
| | - Archith Kamath
- Oxford University Global Surgery Group, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, Oxfordshire, UK
| | - Sai Arathi Parepalli
- Oxford University Global Surgery Group, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, Oxfordshire, UK
| | - Grace Brown
- Oxford University Global Surgery Group, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, Oxfordshire, UK
| | - Sara Iharchane
- Dipartimento di medicina clinica e sperimentale, University of Insubria, Varese, Lombardia, Italy
| | - Sofia Gandino
- Dipartimento di medicina clinica e sperimentale, University of Insubria, Varese, Lombardia, Italy
| | - Zara Markovic-Obiago
- Oxford University Global Surgery Group, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, Oxfordshire, UK
| | - Samuel Scott
- Oxford University Global Surgery Group, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, Oxfordshire, UK
| | - Emery Manirambona
- University of Rwanda College of Medicine and Health Sciences, Kigali, Rwanda
| | - Asif Machhada
- North Bristol NHS Trust, Westbury on Trym, Bristol, UK
| | - Aditi Aggarwal
- Oxford University Global Surgery Group, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, Oxfordshire, UK
| | - Lydia Benazaize
- Oxford University Global Surgery Group, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, Oxfordshire, UK
| | - Mina Ibrahim
- North Bristol NHS Trust, Westbury on Trym, Bristol, UK
| | - David Kim
- Oxford University Global Surgery Group, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, Oxfordshire, UK
| | - Isabel Tol
- Oxford University Global Surgery Group, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, Oxfordshire, UK
| | - Elliott H Taylor
- Oxford University Global Surgery Group, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, Oxfordshire, UK
| | - Alexandra Knighton
- Oxford University Global Surgery Group, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, Oxfordshire, UK
| | - Dorothy Bbaale
- Mbarara University of Science and Technology, Mbarara, Mbarara, Uganda
| | - Duha Jasim
- Oxford University Global Surgery Group, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, Oxfordshire, UK
| | - Heba Alghoul
- Islamic University of Gaza, Gaza, State of Palestine
| | - Henna Reddy
- Oxford University Global Surgery Group, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, Oxfordshire, UK
| | - Hibatullah Abuelgasim
- Oxford University Global Surgery Group, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, Oxfordshire, UK
| | - Kirandeep Saini
- Oxford University Global Surgery Group, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, Oxfordshire, UK
| | | | - Leenah Abuelgasim
- Oxford University Global Surgery Group, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, Oxfordshire, UK
| | - Mario Moran-Romero
- Department of Plastic Surgery, Hospital General Dr. Manuel Gea Gonzalez, National Autonomous University of Mexico, Mexico City, Mexico
| | - Mary Kumarendran
- Oxford University Global Surgery Group, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, Oxfordshire, UK
| | | | - Omaima Ali
- Oxford University Global Surgery Group, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, Oxfordshire, UK
| | - Raghav Sudarshan
- Oxford University Global Surgery Group, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, Oxfordshire, UK
| | - Riley Dean
- University of California San Diego, La Jolla, California, USA
| | - Rumi Kissyova
- North Bristol NHS Trust, Westbury on Trym, Bristol, UK
| | - Sonam Kelzang
- Gelephu Central Regional Referral Hospital, Gelephu, Bhutan
| | - Sophie Roche
- Oxford University Global Surgery Group, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, Oxfordshire, UK
| | - Tazin Ahsan
- Sheikh Hasina National Institute of Burn and Plastic Surgery, Dhaka, Bangladesh
| | - Yethrib Mohamed
- Oxford University Global Surgery Group, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, Oxfordshire, UK
| | - Andile Maqhawe Dube
- National University of Science and Technology Faculty of Medicine, Bulawayo, Zimbabwe
| | - Grace Paida Gwini
- National University of Science and Technology Faculty of Medicine, Bulawayo, Zimbabwe
| | - Rashidah Gwokyala
- Gulu University Faculty of Medicine, Gulu, Uganda
- Oxford Brookes University, Oxford, Oxfordshire, UK
| | - Robin Brown
- Oxford University Global Surgery Group, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, Oxfordshire, UK
| | | | - Zoe Li
- Swansea Bay University Health Board, Port Talbot, Neath Port Talbot, UK
| | | | - Somy Charuvila
- Oxford University Global Surgery Group, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, Oxfordshire, UK
| | - Noel Peter
- Oxford University Global Surgery Group, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, Oxfordshire, UK
| | | | - Nkosikhona Moyo
- National University of Science and Technology Faculty of Medicine, Bulawayo, Zimbabwe
| | - Osaid Alser
- Oxford University Global Surgery Group, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, Oxfordshire, UK
- Harvard Medical School, Boston, Massachusetts, USA
| | - Arielis Solano
- ConnectMed International, Dominican Republic, Dominican Republic
| | | | - Aiman Tariq
- Jinnah Post Graduate Medical Centre, Karachi, Pakistan
| | - Mariam Gaddah
- Lancaster Medical School, Lancaster University, Lancaster, Lancashire, UK
| | - Spyros Kolovos
- Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, Oxford University, Oxford, Oxfordshire, UK
| | - Faith C Muchemwa
- Parirenyatwa Hospital, University of Zimbabwe College of Health Sciences, Harare, Zimbabwe
| | - Abdullah Saleh
- Department of Surgery, University of Alberta, Edmonton, Alberta, Canada
- Office of Global Surgery, University of Alberta, Edmonton, Alberta, Canada
| | - Amanda Gosman
- Department of Surgery, University of Alberta, Edmonton, Alberta, Canada
| | - Rafael Pinedo-Villanueva
- Centre for Statistics in Medicine, University of Oxford, Oxford, Oxfordshire, UK
- MRC Lifecourse Epidemiology Unit, Southampton General Hospital, University of Southampton, Southampton, Hampshire, UK
| | - Anant Jani
- Oxford University Global Surgery Group, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, Oxfordshire, UK
| | - Roba Khundkar
- Oxford University Global Surgery Group, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, Oxfordshire, UK
- North Bristol NHS Trust, Westbury on Trym, Bristol, UK
| |
Collapse
|
22
|
DiPiazza J, Caponnetto P, Askin G, Christos P, Maglia MLP, Gautam R, Roche S, Polosa R. Sensory experiences and cues among E-cigarette users. Harm Reduct J 2020; 17:75. [PMID: 33059666 PMCID: PMC7559939 DOI: 10.1186/s12954-020-00420-0] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2020] [Accepted: 09/26/2020] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND AND AIMS We characterized the extent and quality of respiratory sensations and sensory-related smoking cues associated with e-cigarette use among those who failed to quit combustible tobacco cigarette (CTC) use with traditional FDA approved medications but succeeded in doing so with e-cigarettes. Further, we sought to understand former smokers' perceptions about the influence of sensory experience with e-cigarette use on CTC cessation outcomes. METHODS A nonrandom purposive sample of 156 participants recruited in the USA through the Consumer Advocates for Smoke Free Alternatives Association Facebook page completed an online cross-sectional survey to assess sensory experiences and smoking cues associated with e-cigarette use. Descriptive statistics were calculated, and the ANOVA/Kruskal-Wallis test with post hoc testing and the two-sample t test/Wilcoxon rank-sum test, as appropriate based on distribution, were used to assess the association between sample characteristics and sensory experiences and cues using investigator constructed questions, the Modified Cigarette Evaluation Questionnaire (mCEQ) and the Smoking Cue Appeal Survey (SCAS). RESULTS With e-cigarette use, participants reported feeling the vapor in their throats, windpipes, noses, lungs, and on their tongues; reductions in nicotine craving; and enjoyment of their e-cigarette, including tasting, smelling, and seeing the vapor and touching the device. Women had greater craving reduction than men (p = 0.023). Those who began smoking at 13 years of age or younger had more satisfaction and had greater sensory enjoyment than those who began smoking at 16-17 years of age (p = 0.015 and p = 0.026, respectively), as well as greater sensory enjoyment than those who began smoking at 14-15 years of age (p = 0.047). There was a significant overall association between the number of years a respondent smoked and e-cigarette sensory enjoyment (p = 0.038). Participants 18-34 years old rated e-cigarettes as being more pleasant compared to 45 + years olds, (p = 0.012). Eighty-four percent of participants reported the sensation of the vapor as important in quitting CTCs, and 91% believed the sensations accompanying e-cigarette use contributed to their smoking cessation success. CONCLUSIONS For those who failed to quit previously using approved cessation medications to stop smoking cigarettes, sensory experiences associated with e-cigarette use may help smokers quit smoking.
Collapse
Affiliation(s)
- J DiPiazza
- Hunter Bellevue School of Nursing, Hunter College-City University of New York, New York, NY, USA
| | - P Caponnetto
- Centro per la Prevenzione e Cura del Tabagismo (CPCT), Azienda Ospedaliero-Universitaria "V.Emanuele-Policlinico", Università di Catania, Catania, Italy.
- Institute of Internal Medicine, Azienda Ospedaliero-Universitaria "Policlinico V. Emanuele", Università di Catania, Catania, Italy.
- Institute for Social Marketing, University of Stirling, Stirling, FK9 4LA, UK.
| | - G Askin
- Division of Biostatistics and Epidemiology, Department of Healthcare Policy and Research, Weill Cornell Medicine, New York, NY, USA
| | - P Christos
- Division of Biostatistics and Epidemiology, Department of Healthcare Policy and Research, Weill Cornell Medicine, New York, NY, USA
| | - M Lyc Psych Maglia
- Centro per la Prevenzione e Cura del Tabagismo (CPCT), Azienda Ospedaliero-Universitaria "V.Emanuele-Policlinico", Università di Catania, Catania, Italy
| | - R Gautam
- Clinical and Translational Science Center, Weill Cornell Medicine, New York, NY, USA
| | - S Roche
- Hunter Bellevue School of Nursing, Hunter College-City University of New York, New York, NY, USA
| | - R Polosa
- Centro per la Prevenzione e Cura del Tabagismo (CPCT), Azienda Ospedaliero-Universitaria "V.Emanuele-Policlinico", Università di Catania, Catania, Italy
- Institute of Internal Medicine, Azienda Ospedaliero-Universitaria "Policlinico V. Emanuele", Università di Catania, Catania, Italy
- Center of Excellence for the Acceleration of Harm Reduction (CoEHAR), University of Catania, Catania, Italy
- Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy
| |
Collapse
|
23
|
Abstract
PURPOSE Pregabalin (PRG) is a gamma-aminobutyric acid (GABA) analogue used for treatment of epilepsy, neuropathic pain, generalised anxiety disorder and currently being studied for other indications. Supported by the results of case studies and a limited number of studies, there is an ongoing debate about the addictive potential of PRG. However, evidence is scarce and no definitive assessment on the potential for abuse and dependence to PRG is available. The objective of our study was to identify the number of cases of abuse or dependence to PRG published and to study potential risk factors of addiction to PRG. METHODS We have identified on PubMed and ScienceDirect published case studies of PRG abuse or dependence and analysed these cases on the basis of several clinical parameters. RESULTS A total of 118 cases of PRG abuse or dependence were identified, including 21 isolated cases (mean age 33 years, 67 % men). The mean daily dose of PRG was 2,9 g. Current or past polydrug abuse was present in the majority of cases. Psychiatric diagnoses, other than substance-related disorders, were reported in as many patients, and almost all patients experienced withdrawal symptoms when PRG was discontinued. CONCLUSION Current literature suggests an important and growing concern for the abuse of PRG. Male sex, psychiatric and/or addiction history, including opioid addiction, may be potential risk factors for the development of addictive behaviours associated with PRG.
Collapse
Affiliation(s)
- S Roche
- Centre médical Marmottan, 17-19, rue d'Armaillé, 75017 Paris, France.
| | - M Blaise
- Centre médical Marmottan, 17-19, rue d'Armaillé, 75017 Paris, France
| |
Collapse
|
24
|
Shock DA, Coe JB, LeBlanc SJ, Leslie KE, Renaud D, Roche S, Hand K, Godkin MA, Kelton DF. Characterizing the attitudes and motivations of Ontario dairy producers toward udder health. J Dairy Sci 2020; 103:4618-4632. [PMID: 32147271 DOI: 10.3168/jds.2019-16621] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2019] [Accepted: 01/02/2020] [Indexed: 11/19/2022]
Abstract
Considerable research has focused on identifying risk factors for intramammary infections, yet mastitis remains a pervasive disease on dairy farms. Increasingly, researchers are appreciating the role of dairy producer mindset in determining management style and thus udder health status of the herd. The objective of this study was to explore the attitudes and motivations of Ontario dairy farmers toward udder health in herds with varying bulk milk somatic cell count (BMSCC). In December 2011, 5 focus groups were conducted across Ontario, Canada, with independent groups of dairy producers representing low, medium, and high BMSCC herds. Groups were established based on producer's weighted BMSCC levels as recorded over the summer of 2011. A semi-structured interview guide was followed to discuss topics relating to udder health. Thematic analysis was performed on the interview transcripts. Generally, producers noted management techniques (specifically culling infected cows and monitoring BMSCC), a perceived wealth of information on mastitis control, and a proactive whole-herd management approach engender the perception of control over mastitis. Producers in the low BMSCC group were confident in their level of knowledge and control of mastitis in their herds, whereas high BMSCC producers generally felt lower levels of control. Several areas were identified by producers that counteract this perception, contributing to perceived low levels of control over mastitis. Participants identified that at certain times they do not understand the cause of BMSCC on their farm. This attitude was especially prominent in the high BMSCC group. Other times, producers cited improper sample handling, seasonal issues, perceived milk culture shortcomings, and low herd size as factors that limited their control over mastitis in their herds. Though producers generally have high levels of self-efficacy beliefs when it comes to udder health management, the perception still exists that, under certain situations, mastitis is uncontrollable. This highlights the fact that educational and extension efforts need to focus on ensuring that producers employ proven mastitis diagnostic, prevention, and treatment practices in a systematic manner, with realistic expectations.
Collapse
Affiliation(s)
- D A Shock
- ACER Consulting, Guelph, Ontario, N1G 5L3, Canada
| | - J B Coe
- Department of Population Medicine, University of Guelph, Guelph, Ontario, Canada, N1G 2W1
| | - S J LeBlanc
- Department of Population Medicine, University of Guelph, Guelph, Ontario, Canada, N1G 2W1
| | - K E Leslie
- Department of Population Medicine, University of Guelph, Guelph, Ontario, Canada, N1G 2W1
| | - D Renaud
- ACER Consulting, Guelph, Ontario, N1G 5L3, Canada; Department of Population Medicine, University of Guelph, Guelph, Ontario, Canada, N1G 2W1
| | - S Roche
- ACER Consulting, Guelph, Ontario, N1G 5L3, Canada; Department of Population Medicine, University of Guelph, Guelph, Ontario, Canada, N1G 2W1
| | - K Hand
- ACER Consulting, Guelph, Ontario, N1G 5L3, Canada
| | - M A Godkin
- Veterinary Science and Policy Group, Ontario Ministry of Agriculture and Food, Guelph, Ontario, Canada, N1G 4Y2
| | - D F Kelton
- Department of Population Medicine, University of Guelph, Guelph, Ontario, Canada, N1G 2W1.
| |
Collapse
|
25
|
Celma A, López R, Roche S, Planas J, Regis L, Placer J, Borque A, Esteban L, de Torres I, Morote J. Are targeted prostate biopsies ready to replace systematic prostate biopsies? Actas Urol Esp 2019; 43:573-578. [PMID: 31679807 DOI: 10.1016/j.acuro.2018.06.011] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/29/2017] [Revised: 06/07/2018] [Accepted: 06/09/2018] [Indexed: 12/27/2022]
Abstract
OBJECTIVES To evaluate the efficacy and efficiency of systematic prostatic biopsy (SPB) and cognitive fusion PB (CFPB) to diagnose prostate cancer (PCa) and significant PCa (SPCa), and to analyse if CFPB could safely replace SPB. MATERIAL AND METHODS A cohort of 314 consecutive men having PI-RADS ≥2 in a pre-biopsy 3T mp-MRI were prospectively subjected to trans-rectal ultrasound CFPB (two cores per suspicious area until a maximum of three areas) and a 12 peripheral core SPB. SPCa was considered when the WHO grade was higher than 2 (Gleason 4+3 or higher). RESULTS PCa was diagnosed in 133 patients (42.4%), being 83 (62.4%) SPCa. SPB detected PCa in 114 men (85.7%) while CFPB in 103 (77.4%), P<.001. SPB detected SPCa in 64 men (77.1%) while CFPB in 71 (85.5%), P<.001. In 52 of the 81 men (64.2%) SPCa was detected in SPB and CFPB. In 19 men SPCa was only detected in CFPB (23.5%) while in 10, it was only detected in SPB (12.3%). 33.1 cores were needed to diagnose one PCa in SPB while 8.5 in CFPB, P<.001. 58.9 cores were needed to diagnose one SPCa in SPB, while 12.4 in CFPB, P<.001. CONCLUSIONS CFPB are more effective and also more efficient than SPBs in detecting SPCa. However, CFPBs still can't safely replace SPBs because they are not able to detect up to 15% of SPCa.
Collapse
|
26
|
Faeghi S, Roche S. Environmental Configurations. Anthropology of the Middle East 2019. [DOI: 10.3167/ame.2019.140203] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Among the many consequences of Iran’s suffering from water shortage in recent decades, the major river of Isfahan city, Zayandeh Rud, has dried out. While experts observe this issue through environmental discourses and local farmers engage in political protests, citizens phrase the loss of the river as a cultural catastrophe. Within the environmental configuration that includes the river, historical buildings, parks, fauna, flora and humans, habitual relationships produce a sense of security and well-being. Since the drought, this configuration has been seriously affected. We suggest the drought is experienced as sociocultural disaster because Zayandeh Rud is a central element for the creation of social, cultural, economic and political relationships. Following the suggestion of Tim Ingold, we conceptualise the environment as the interplay between the German notion of Umwelt (out world) and Innenwelt (subjective world).
Collapse
Affiliation(s)
| | - Sophie Roche
- Heidelberg Cluster for Transcultural Studies, University of Heidelberg
| |
Collapse
|
27
|
Eustace A, Roche S, Mukherjee N, O’Neill F, Conlon N, Meiller J, Collins D, Gaule P, Canonici A, Madden S, O’Donovan N, Crown J. Preclinical evaluation targeting both IGF1R and IR in triple negative breast cancer. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz268.069] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
28
|
Sevinçli H, Roche S, Cuniberti G, Brandbyge M, Gutierrez R, Medrano Sandonas L. Green function, quasi-classical Langevin and Kubo-Greenwood methods in quantum thermal transport. J Phys Condens Matter 2019; 31:273003. [PMID: 31026228 DOI: 10.1088/1361-648x/ab119a] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
With the advances in fabrication of materials with feature sizes at the order of nanometers, it has been possible to alter their thermal transport properties dramatically. Miniaturization of device size increases the power density in general, hence faster electronics require better thermal transport, whereas better thermoelectric applications require the opposite. Such diverse needs bring new challenges for material design. Shrinkage of length scales has also changed the experimental and theoretical methods to study thermal transport. Unsurprisingly, novel approaches have emerged to control phonon flow. Besides, ever increasing computational power is another driving force for developing new computational methods. In this review, we discuss three methods developed for computing vibrational thermal transport properties of nano-structured systems, namely Green function, quasi-classical Langevin, and Kubo-Green methods. The Green function methods are explained using both nonequilibrium expressions and the Landauer-type formula. The partitioning scheme, decimation techniques and surface Green functions are reviewed, and a simple model for reservoir Green functions is shown. The expressions for the Kubo-Greenwood method are derived, and Lanczos tridiagonalization, continued fraction and Chebyshev polynomial expansion methods are discussed. Additionally, the quasi-classical Langevin approach, which is useful for incorporating phonon-phonon and other scatterings is summarized.
Collapse
Affiliation(s)
- H Sevinçli
- Department of Materials Science and Engineering, Izmir Institute of Technology, 35430, Urla, Izmir, Turkey
| | | | | | | | | | | |
Collapse
|
29
|
Roche S, Lara-Pompa NE, Macdonald S, Fawbert K, Valente J, Williams JE, Hill S, Wells JC, Fewtrell MS. Bioelectric impedance vector analysis (BIVA) in hospitalised children; predictors and associations with clinical outcomes. Eur J Clin Nutr 2019; 73:1431-1440. [PMID: 31076656 DOI: 10.1038/s41430-019-0436-7] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2018] [Revised: 03/31/2019] [Accepted: 04/18/2019] [Indexed: 12/27/2022]
Abstract
BACKGROUND Clinical use of bioelectric impedance is limited by variability in hydration. Analysis of raw bioelectric impedance vectors (BIVA), resistance (R), reactance (Xc) and phase angle (PA) may be an alternative for monitoring disease progression/treatment. Clinical experience of BIVA in children is limited. We investigated predictors of BIVA and their ability to predict clinical outcomes in children with complex diagnoses. METHODS R, Xc and PA were measured (BODYSTAT Quadscan 4000) on admission in 108 patients (4.6-16.8 years, mean 10.0). R and Xc were indexed by height (H) and BIVA-SDS for age and sex calculated using data from healthy children. Potential predictors and clinical outcomes (greater-than-expected length-of-stay (LOS), complications) were recorded. RESULTS Mean R/H-SDS was significantly higher (0.99 (SD 1.32)) and PA-SDS lower (-1.22 (1.68))) than expected, with a wide range for all parameters. In multivariate models, the Strongkids risk category predicted R/H-SDS (adjusted mean for low, medium and high risk = 0.49, 1.28, 2.17, p = 0.009) and PA-SDS (adjusted mean -0.52, -1.53, -2.36, p = 0.01). BIVA-SDS were not significantly different in patients with or without adverse outcomes. CONCLUSIONS These complex patients had abnormal mean BIVA-SDS suggestive of reduced hydration and poor cellular health according to conventional interpretation. R/H-SDS was higher and PA-SDS lower in those classified as higher malnutrition risk by the StrongKids tool. Further investigation in specific patient groups, including those with acute fluid shifts and using disease-specific outcomes, may better define the clinical role of BIV.
Collapse
Affiliation(s)
- S Roche
- Childhood Nutrition Research Centre, UCL Great Ormond Street Institute of Child Health, London, UK.,Great Ormond Street Hospital for Children NHS Trust, London, UK
| | - N E Lara-Pompa
- Childhood Nutrition Research Centre, UCL Great Ormond Street Institute of Child Health, London, UK.,Great Ormond Street Hospital for Children NHS Trust, London, UK
| | - S Macdonald
- Childhood Nutrition Research Centre, UCL Great Ormond Street Institute of Child Health, London, UK.,Great Ormond Street Hospital for Children NHS Trust, London, UK
| | - K Fawbert
- Childhood Nutrition Research Centre, UCL Great Ormond Street Institute of Child Health, London, UK.,Great Ormond Street Hospital for Children NHS Trust, London, UK
| | - J Valente
- Childhood Nutrition Research Centre, UCL Great Ormond Street Institute of Child Health, London, UK.,Great Ormond Street Hospital for Children NHS Trust, London, UK
| | - J E Williams
- Childhood Nutrition Research Centre, UCL Great Ormond Street Institute of Child Health, London, UK.,Great Ormond Street Hospital for Children NHS Trust, London, UK
| | - S Hill
- Childhood Nutrition Research Centre, UCL Great Ormond Street Institute of Child Health, London, UK.,Great Ormond Street Hospital for Children NHS Trust, London, UK
| | - J C Wells
- Childhood Nutrition Research Centre, UCL Great Ormond Street Institute of Child Health, London, UK.,Great Ormond Street Hospital for Children NHS Trust, London, UK
| | - M S Fewtrell
- Childhood Nutrition Research Centre, UCL Great Ormond Street Institute of Child Health, London, UK. .,Great Ormond Street Hospital for Children NHS Trust, London, UK.
| |
Collapse
|
30
|
Regis L, Salazar A, Cuadras M, Miret E, Roche S, Celma A, Planas J, Lorente D, Placer J, Trilla E, Morote J. Preoperative magnetic resonance imaging in predicting early continence recovery after robotic radical prostatectomy. Actas Urol Esp 2019; 43:137-142. [PMID: 30420112 DOI: 10.1016/j.acuro.2018.07.003] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/08/2018] [Revised: 06/29/2018] [Accepted: 07/02/2018] [Indexed: 12/23/2022]
Abstract
INTRODUCTION AND AIMS Urinary incontinence is a common complication after radical prostatectomy. The aim of our study was to describe the preoperative anatomical features using magnetic resonance imaging in order to predict early continence recovery after robotic radical prostatectomy. MATERIAL AND METHODS 72 patients who underwent robotic radical prostatectomy were prospectively analysed. EPIC questionnaire (1, 6 and 12 mo) and first self-reported continence were used to assess functional outcomes. Membranous urethral length (MUL) and MUL-prostate axis angle (aMULP) were assessed preoperatively on T2 weighted sagittal images. RESULTS Continence rate was 67.2%, 92.6% and 95.2% at 1, 6 and 12 months, respectively. Early continence was achieved in patients with the lower aMULP. At 1 month, average aMULP in continent patients was 107.21° (IC 95% 90.3-124.6) vs. 118.5° (IC 95% 117.7-134) in incontinent ones (P=.014). At 6 month differences in aMULP among groups were found: 114.24° (IC 95% 104.6-123.9) in continents vs. 142° (IC 95% 126.5-157.6) in incontinents (P=0.015). At 12 month, continent group showed a significantly higher preoperative aMULP. aMULP was revealed as the only independent predictor of urinary continence at 6 mo in multivariate analysis, OR 0.007 (IC 95% 0.002-0.012), P=0.012. CONCLUSIONS Preoperative anatomical parameters assessment prior surgery can help to identified those patients will achieve early continence recovery and it supports therapeutic decisions making.
Collapse
Affiliation(s)
- L Regis
- Departamento de Urología, Hospital Universitari Vall d' Hebron, Universitat Autonoma de Barcelona, Barcelona, España.
| | - A Salazar
- Departamento de Urología, Hospital Universitari Vall d' Hebron, Universitat Autonoma de Barcelona, Barcelona, España
| | - M Cuadras
- Departamento de Urología, Hospital Universitari Vall d' Hebron, Universitat Autonoma de Barcelona, Barcelona, España
| | - E Miret
- Departamento de Urología, Hospital Universitari Vall d' Hebron, Universitat Autonoma de Barcelona, Barcelona, España
| | - S Roche
- Institut de Imatge i Diagnostic, Hospital Universitari Vall d' Hebron, Universitat Autonoma de Barcelona, Barcelona, España
| | - A Celma
- Departamento de Urología, Hospital Universitari Vall d' Hebron, Universitat Autonoma de Barcelona, Barcelona, España
| | - J Planas
- Departamento de Urología, Hospital Universitari Vall d' Hebron, Universitat Autonoma de Barcelona, Barcelona, España
| | - D Lorente
- Departamento de Urología, Hospital Universitari Vall d' Hebron, Universitat Autonoma de Barcelona, Barcelona, España
| | - J Placer
- Departamento de Urología, Hospital Universitari Vall d' Hebron, Universitat Autonoma de Barcelona, Barcelona, España
| | - E Trilla
- Departamento de Urología, Hospital Universitari Vall d' Hebron, Universitat Autonoma de Barcelona, Barcelona, España
| | - J Morote
- Departamento de Urología, Hospital Universitari Vall d' Hebron, Universitat Autonoma de Barcelona, Barcelona, España
| |
Collapse
|
31
|
Conlon N, McDermott M, Browne B, Roche S, O'Neill F, Meiller J, Browne A, Eustace A, Collins DM, O'Donovan N, Crown J. Abstract P5-03-02: Pre-clinical investigation of PP2A inhibitor LB-100 in overcoming and preventing lapatinib resistance in HER2-positive breast cancer. Cancer Res 2019. [DOI: 10.1158/1538-7445.sabcs18-p5-03-02] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: HER2-positive breast cancer (BC) accounts for approximately 15% of all BC. HER2-targeted therapies, such as trastuzumab and lapatinib, have significantly improved the outcome for these patients. However, HER2-targeted therapy resistance is a common clinical issue. We have previously shown that protein phosphatase 2A (PP2A) plays a role in mediating acquired lapatinib resistance in HER2-positive BC and that response to lapatinib is enhancedin vitroby the lab-grade PP2A inhibitor, okadaic acid. The aim of this study was to examine the in vitro and in vivo efficacy of LB-100, a PP2A inhibitor that has completed phase I clinical testing (NCT01837667), in models of HER2-positive BC with acquired resistance to lapatinib.
Methods: HER2-positiveSKBR3 and HCC1954 BC cell lines were treated with 250 nM or 1 μM lapatinib, respectively, for 6 months to generate lapatinib-resistant SKBR3-L and HCC1954-L cell lines. In vitro sensitivity to lapatinib and LB-100 was assessed by 2D acid phosphatase assay. Combination index (CI) values were generated to identify synergistic combinations. Propidium iodide staining was used to determine cell cycle arrest and apoptosis. In order to examine the in vivo efficacy of LB-100, HCC1954-L cells were implanted into the mammary fat pad of BALB/c nude mice and treated with vehicle, lapatinib, LB-100, or lapatinib plus LB-100. To examine the prevention of the development of lapatinib resistance, SKBR3 and HCC1954 cells were treated twice weekly with lapatinib, LB-100 or the combination and stained with crystal violet when confluent.
Results: SKBR3-L and HCC1954-L cells were resistant to lapatinib at clinically relevant concentrations (IC50values = 2.37 ± 0.58 μM and 1.67 ± 0.34 μM). This represents a 46- and 5.2-fold decrease in lapatinib sensitivity. LB-100 had a greater anti-proliferative effect in the lapatinib-resistant SKBR3-L and HCC1954-L cell lines compared to their respective parental cell lines (IC50values = 2.12 ± 0.2 μM v 5.38 ± 0.6 μM, and 2.31 ± 0.19 μM v 5.32 ± 0.82 μM, respectively). LB-100 overcame lapatinib resistance in both models, as lapatinib plus LB-100 was synergistic in both cell lines (CI values = 0.56 ± 0.13 and 0.68 ±0.26). LB-100 caused cell death through the induction of apoptosis in SKBR3- L (p = 0.019) and HCC1954-L (p = 0.046) and the addition of lapatinib to LB-100 increased apoptotic induction in HCC1954-L cells (p=0.046).Lapatinib plus LB-100 was well tolerated in vivo. The HCC1954-L cell line maintained resistance to lapatinib in vivo and the combination of lapatinib and LB-100 significantly reduced HCC1954-L tumour volume compared to all other treatment arms (p = 0.0006). Interestingly, in vitro short-term resistance assays showed that the addition of LB-100 to lapatinib could also block the emergence of lapatinib resistance in both parental SKBR3 and HCC1954 cell lines.
Conclusions: This study indicates that LB-100 has in vitro and in vivo efficacy against lapatinib-resistant HER2-positive BC cell line models and justifies further investigation into its potential to circumvent or prevent lapatinib resistance in HER2-positive BC.
Citation Format: Conlon N, McDermott M, Browne B, Roche S, O'Neill F, Meiller J, Browne A, Eustace A, Collins DM, O'Donovan N, Crown J. Pre-clinical investigation of PP2A inhibitor LB-100 in overcoming and preventing lapatinib resistance in HER2-positive breast cancer [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr P5-03-02.
Collapse
Affiliation(s)
- N Conlon
- National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland; St. Vincent's University Hospital, Dublin, Ireland
| | - M McDermott
- National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland; St. Vincent's University Hospital, Dublin, Ireland
| | - B Browne
- National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland; St. Vincent's University Hospital, Dublin, Ireland
| | - S Roche
- National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland; St. Vincent's University Hospital, Dublin, Ireland
| | - F O'Neill
- National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland; St. Vincent's University Hospital, Dublin, Ireland
| | - J Meiller
- National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland; St. Vincent's University Hospital, Dublin, Ireland
| | - A Browne
- National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland; St. Vincent's University Hospital, Dublin, Ireland
| | - A Eustace
- National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland; St. Vincent's University Hospital, Dublin, Ireland
| | - DM Collins
- National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland; St. Vincent's University Hospital, Dublin, Ireland
| | - N O'Donovan
- National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland; St. Vincent's University Hospital, Dublin, Ireland
| | - J Crown
- National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland; St. Vincent's University Hospital, Dublin, Ireland
| |
Collapse
|
32
|
Curtit E, Vannetzel JM, Darmon JC, Roche S, Bourgeois H, Dewas S, Catala S, Mereb E, Fanget CF, Genet D, Forest AM, Bernier C, Pivot X. Results of PONDx, a prospective multicenter study of the Oncotype DX ® breast cancer assay: Real-life utilization and decision impact in French clinical practice. Breast 2019; 44:39-45. [PMID: 30634106 DOI: 10.1016/j.breast.2018.12.015] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/19/2018] [Revised: 12/28/2018] [Accepted: 12/31/2018] [Indexed: 12/11/2022] Open
Abstract
Adjuvant chemotherapy shows clear benefits in HER2-positive and triple-negative breast cancer (BC). Its benefits are less universal in BCs expressing hormone receptors. The 21-gene Oncotype DX® Breast Recurrence Score test was designed for HR+, HER2- early-stage BC before decision on adjuvant chemotherapy. Its validity and utility was demonstrated prospectively across multiple studies. The observational study PONDx characterized the use of Oncotype DX® Breast in routine practice in France and evaluated its decision impact. Of 882 ER-positive BC patients (67% postmenopausal), most (79%) had N0/Nmic node involvement, grade 2 tumors (68%), tumor size 1-5 cm (88%), and ductal histology (78%). BCs with histopathologically elevated recurrence risk included grade 3: 18%; N1: 21%; Ki67 > 20%: 31%. Recurrence Score results by prognostic category were: <18: 54%, 18-30: 36%; >30: 10%. Compared to recommendations before individual availability of the score, results prompted net absolute reductions in chemotherapy recommendations of 36% (total population), and 29% (grade 3 and/or Ki67 > 20% histologies). Decisions reflected prognostic implications: in the Recurrence Score <18 category, 95% of patients received recommendations of hormonal therapy only, in the >30 category, 97.5% were recommended additional chemotherapy; 95% followed the final recommendations of their physicians. The Recurrence Score provides independent predictive and prognostic information in ER + N0/N1 early BC, including high-risk subgroups. PONDx further characterizes the population where the test is beneficial in real-life use and fits current clinical needs. Oncotype DX® Breast enables relevant net reductions in chemotherapy use, sparing patients from serious toxicities. Its therapeutic implications are highly accepted by physicians and patients.
Collapse
Affiliation(s)
- Elsa Curtit
- Institut Régional Fédératif du Cancer pour la Région Franche-Comté, Université de Bourgogne Franche-Comté, Pôle Cancero-Biologie, 2 Bd Fleming, 25000, Besançon, France.
| | | | - Jean-Claude Darmon
- ICA-Polyclinique Urbain V, 95 Chemin du Pont des Deux Eaux, 84000, Avignon, France.
| | - Sophie Roche
- Centre Jean Bernard, 9 Rue Beauverger, 72000, Le Mans, France.
| | | | - Sylvain Dewas
- Centre Bourgogne - Polyclinique du Bois, 44 Avenue Marx Dormoy, 59000, Lille, France.
| | - Stéphanie Catala
- Centre Catalan d'Oncologie, 80 Rue Pascal Marie Agasse, 66000, Perpignan, France.
| | - Emile Mereb
- Hôpital Manchester - Centre Hospitalier de Charleville-Mézières, 45 Avenue de Manchester, Charleville-Mézières, France.
| | - Charlotte Furtos Fanget
- Institut de Cancérologie Lucien Neuwirth, 108bis Avenue Albert Raimond, 42270, Saint-Priest-en-Jarez, France.
| | - Dominique Genet
- Clinique François Chenieux, 18 Rue du Général Catroux, 87000, Limoges, France.
| | - Anne-Marie Forest
- Centre Hospitalier de Montluçon 18, Avenue du 8 Mai 1945, 03113, Montluçon, France.
| | - Céline Bernier
- 3C Sud Ile de France, Centre de Coordination en Cancérologie Inter-établissements, Centre Hospitalier de Bligny, 91640, Briis-sous-Forges, France.
| | - Xavier Pivot
- Institut Régional du Cancer, 3 Rue de la Porte de l'hôpital, 67065, Strasbourg, France.
| |
Collapse
|
33
|
Engelmann EWM, Maqungo S, Laubscher Μ, Hoppe S, Roche S, Nicol A, Navsaria P, Held M. Epidemiology and injury severity of 294 extremity gunshot wounds in ten months: a report from the Cape Town trauma registry. SA orthop j 2019. [DOI: 10.17159/2309-8309/2019/v18n2a3] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
|
34
|
Nguyen K, Roche S, Lavoute C, Reant P, Donal E, Haentjens J, Consolino E, Odent S, Habib G, Eicher JC, Faivre L, Rooryck-Thambo C, Charron P, Casalta A, Michel N. Genetic spectrum of hypertrophic cardiomyopathy revisited. Whole Exome Sequencing reveals extreme genetic heterogeneity, new gene mutations in a multicenter series of 200 patients. Archives of Cardiovascular Diseases Supplements 2019. [DOI: 10.1016/j.acvdsp.2018.10.059] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
35
|
Martinez S, Leflem C, Nahon S, Roche S, Tadrist Z, Bernardi M. Programme d’éducation thérapeutique en cancérologie (SMILE). Rev Mal Respir 2019. [DOI: 10.1016/j.rmr.2018.10.448] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
36
|
Merviel P, Bouée S, Ménard M, Le Martelot MT, Roche S, Lelièvre C, Chabaud JJ, Jacq C, Drapier H, Beauvillard D. [Which ovarian stimulation to which women: The polycystic ovary syndrome (PCOS)]. ACTA ACUST UNITED AC 2018; 45:623-631. [PMID: 29100822 DOI: 10.1016/j.gofs.2017.10.001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/06/2017] [Accepted: 10/01/2017] [Indexed: 10/18/2022]
Abstract
Polycystic ovarian syndrome (PCOS) is a frequent pathology in the young woman, linking infertility to a metabolic disease. Initial support will include a plan (in the case of overweight or obesity) to lose at least 5 to 10% of the weight. Subsequently, clomiphene citrate is the first treatment for ovulation induction with pregnancy rates of 40 to 80% after 6 cycles. If there is resistance to clomiphene citrate, the choice will be between the ovarian drilling (50-60% of pregnancy in the year following, including the half spontaneous) or ovarian stimulation with gonadotropins. The risk of ovarian stimulation in these women is hyperstimulation and multiple pregnancies. We also discuss the place of the GnRH pulsatile administration, insulin-sensitizers, in vitro fertilization and in vitro maturation in these women. Once infertility support, these women should be long-term followed because of the neoplasic and cardiovascular risks they present.
Collapse
Affiliation(s)
- P Merviel
- Fédération d'assistance médicale à la procréation, CHRU de Brest, hôpital Morvan, 2, avenue Foch, 29200 Brest, France.
| | - S Bouée
- Fédération d'assistance médicale à la procréation, CHRU de Brest, hôpital Morvan, 2, avenue Foch, 29200 Brest, France
| | - M Ménard
- Fédération d'assistance médicale à la procréation, CHRU de Brest, hôpital Morvan, 2, avenue Foch, 29200 Brest, France
| | - M-T Le Martelot
- Fédération d'assistance médicale à la procréation, CHRU de Brest, hôpital Morvan, 2, avenue Foch, 29200 Brest, France
| | - S Roche
- Fédération d'assistance médicale à la procréation, CHRU de Brest, hôpital Morvan, 2, avenue Foch, 29200 Brest, France
| | - C Lelièvre
- Fédération d'assistance médicale à la procréation, CHRU de Brest, hôpital Morvan, 2, avenue Foch, 29200 Brest, France
| | - J-J Chabaud
- Fédération d'assistance médicale à la procréation, CHRU de Brest, hôpital Morvan, 2, avenue Foch, 29200 Brest, France
| | - C Jacq
- Fédération d'assistance médicale à la procréation, CHRU de Brest, hôpital Morvan, 2, avenue Foch, 29200 Brest, France
| | - H Drapier
- Fédération d'assistance médicale à la procréation, CHRU de Brest, hôpital Morvan, 2, avenue Foch, 29200 Brest, France
| | - D Beauvillard
- Fédération d'assistance médicale à la procréation, CHRU de Brest, hôpital Morvan, 2, avenue Foch, 29200 Brest, France
| |
Collapse
|
37
|
Morard M, Gonzalez Monge S, Rippert P, Roche S, Bernard J, Lagauche D, Delvert C, Luauté J, Jacquin Courtois S, Caillet F, Di Marco J, Ghelfi F, Otmani S, Calmels P, Marjorie R, Joseph P, Ecochard R, Rode G, Vuillerot C. A new physical and cognitive activities score: the Sofmer activity score (SAS). The feasilibity study. Ann Phys Rehabil Med 2018. [DOI: 10.1016/j.rehab.2018.05.1242] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
38
|
Roche S, Blaise M. Accompagnement médico-psycho-social des addictions. L'Aide-Soignante 2018; 32:15-18. [DOI: 10.1016/j.aidsoi.2018.05.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 09/02/2023]
|
39
|
Morard MD, Gonzalez-Monge S, Rippert P, Roche S, Bernard JC, Lagauche D, Delvert C, Luauté J, Jacquin-Courtois S, Caillet F, Di Marco J, Ghelfi F, Otmani S, Calmels P, Royet M, Joseph PA, Ecochard R, Rode G, Vuillerot C. Construction and feasibility study of the SOFMER Activity Score (SAS), a new assessment of physical and cognitive activity. Ann Phys Rehabil Med 2018; 61:315-322. [PMID: 29777770 DOI: 10.1016/j.rehab.2018.04.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/04/2018] [Revised: 04/18/2018] [Accepted: 04/20/2018] [Indexed: 10/16/2022]
Abstract
OBJECTIVES For hospitalizations in rehabilitation centers (RCs) in France, the quantification of healthcare givers' activity is based on the dependency of the patients, defined as a total or partial inability to perform activities required for daily living without help. The tools currently used to quantify dependency are not sufficiently precise. Here we describe the construction of a new tool, the SOFMER Activity Score (SAS scoring), which allows for a good description of the level of activity of patients hospitalized in RCs, and a feasibility study of the tool. METHODS After a study group proposed the first version of the SAS, the validity of its content was studied by the Delphi consensus method: 26 physicians or healthcare professionals known for their expertise in PMR responded to the first round. The feasibility study was prospective and involved multi-site professionals. Data related to the SAS determined by a multidisciplinary team were collected and compared to the Activité de la Vie Quotidienne (AVQ) scale, which is administered to all patients and included in medical and administrative data. RESULTS We included 81 patients in the feasibility study. The mean (SD) time to obtain the SAS was 4.5 (3.3) min. For 97.5% of scorings, the participating professionals judged that the SAS was compatible or fairly compatible with clinical practice. The internal structure of the SAS scale seemed better than that of the AVQ scale, for which the present study confirmed a floor effect for all items. CONCLUSIONS The SAS allows for measuring the level of physical and cognitive activity of a patient hospitalized in an RC. If validation studies for the SAS, exploring its reliability, construct validity or criterion validity, confirm the tool's good metrological qualities, the SAS will allow for a good quantification of the burden of care.
Collapse
Affiliation(s)
- M D Morard
- Service de médecine physique et de réadaptation pédiatrique, hospices civils de Lyon, hôpital Femme-Mère-Enfant, L'Escale, 69500 Bron, France; Équipe dysfonction vasculaire et hémostase (DVH), Inserm, UMR1059 Sainbiose, université de Lyon, université Jean-Monnet, 42023 Saint-Étienne, France
| | - S Gonzalez-Monge
- Service de médecine physique et de réadaptation pédiatrique, hospices civils de Lyon, hôpital Femme-Mère-Enfant, L'Escale, 69500 Bron, France
| | - P Rippert
- Pôle santé publique, service recherche et épidémiologie clinique, hospices civils de Lyon, 69003 Lyon, France
| | - S Roche
- Service de biostatistique, hospices civils de Lyon, 69003 Lyon, France
| | - J C Bernard
- CMCR des Massues - Croix Rouge française, 69005 Lyon, France
| | - D Lagauche
- Clinique IRIS, 69800 Saint Priest, France
| | - C Delvert
- Service de médecine physique et de réadaptation pédiatrique, hospices civils de Lyon, hôpital Femme-Mère-Enfant, L'Escale, 69500 Bron, France; Union RESAMUT - Pouponnière la Fougeraie, 69370 Saint-Didier-au-Mont-d'Or, France
| | - J Luauté
- Service de médecine physique et de réadaptation neurologique, hospices civils de Lyon, hôpital Henry-Gabrielle, 69230 Saint-Genis-Laval, France
| | - S Jacquin-Courtois
- Service de médecine physique et réadaptation, hospices civils de Lyon, hôpital Henry-Gabrielle, 69230 Saint-Genis-Laval, France
| | - F Caillet
- Service de médecine physique et réadaptation, hospices civils de Lyon, hôpital Henry-Gabrielle, 69230 Saint-Genis-Laval, France
| | - J Di Marco
- Service de médecine physique et réadaptation, hospices civils de Lyon, hôpital Henry-Gabrielle, 69230 Saint-Genis-Laval, France
| | - F Ghelfi
- Hospices civils de Lyon, direction centrale des soins, 69002 Lyon, France
| | - S Otmani
- Pôle santé publique, service recherche et épidémiologie clinique, hospices civils de Lyon, 69003 Lyon, France
| | - P Calmels
- Service de médecine physique et de réadaptation, CHU de Saint-Etienne, hôpital Bellevue, 42000 Saint-Etienne, France
| | - M Royet
- Service de médecine physique et de réadaptation pédiatrique, hospices civils de Lyon, hôpital Femme-Mère-Enfant, L'Escale, 69500 Bron, France
| | - P A Joseph
- Service de médecine physique et de réadaptation, CHU de Bordeaux, hôpital Saint-André et Pellegrin, pôle neurosciences cliniques, 33000 Bordeaux, France; Unité EA4136 handicap et système nerveux, université de Bordeaux 2, 33000 Bordeaux, France
| | - R Ecochard
- Service de biostatistique, hospices civils de Lyon, 69003 Lyon, France; Équipe biostatistique santé, CNRS UMR 5558, laboratoire de biométrie et biologie evolutive, 69310 Pierre-Bénite, France
| | - G Rode
- Hospices civils de Lyon, direction centrale des soins, 69002 Lyon, France; Inserm UMR-S 1028, CNRS UMR 5292, impact, centre de recherche en neurosciences de Lyon, université Lyon 1, 69000 Lyon, France
| | - C Vuillerot
- Service de médecine physique et de réadaptation pédiatrique, hospices civils de Lyon, hôpital Femme-Mère-Enfant, L'Escale, 69500 Bron, France; Équipe biostatistique santé, CNRS UMR 5558, laboratoire de biométrie et biologie evolutive, 69310 Pierre-Bénite, France; Université Lyon I, 69100 Villeurbanne, France; Université de Lyon, 69000 Lyon, France.
| | | |
Collapse
|
40
|
Moranne O, Fafin C, Roche S, Francois M, Allot V, Potier J, Babici D, Lobbedez T, Matignon M, Mariat C, Vigneau C, Couchoud C. Treatment plans and outcomes in elderly patients reaching advanced chronic kidney disease. Nephrol Dial Transplant 2018; 33:2182-2191. [DOI: 10.1093/ndt/gfy046] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/05/2017] [Accepted: 01/16/2018] [Indexed: 11/12/2022] Open
Affiliation(s)
- Olivier Moranne
- Service de Néphrologie-Dialyses-Aphérèse CHU Caremeau, Nimes, France
- Institut Universitaire de Recherche Clinique–EA2415–Epidémiologie, biostatistiques et santé publique; Faculté de Médecine, Université de Montpellier-Nimes, France
| | - Coraline Fafin
- Service de Néphrologie-Dialyses-Aphérèse CHU Caremeau, Nimes, France
| | - Sophie Roche
- Service de Néphrologie-Dialyse CH Macon, Macon, France
| | - Maud Francois
- Service de Néphrologie-Dialyse-Transplantation, CHU Tours, France
| | - Vincent Allot
- CHU Limoges, Service de Néphrologie, Dialyse, Transplantation, Limoges, France
| | - Jerome Potier
- Service de Néphrologie-Dialyse, CH de Saint Brieuc, Saint Brieuc, France
| | - Daniela Babici
- Hôpital Emile Muller, Service Néphrologie-Dialyse, GHR MSA, Mulhouse, France
| | - Thierry Lobbedez
- CHU Caen Service de Néphrologie, Dialyse, Transplantation, Caen, France
| | - Marie Matignon
- Service Nephrologie-Dialyse-Transplantation, AP-HP, Hopital Henri Mondor, Créteil, France
| | - Christophe Mariat
- CHU St Etienne, Service Nephrologie Dialyse Transplantation, St Etienne, France
| | - Cecile Vigneau
- CHU Pontchaillou, service de Néphrologie-Dialyse-Transplantation, Rennes, Université Rennes 1, IRSET, France
| | - Cecile Couchoud
- Registre REIN, Agence de la Biomedecine, Saint-Denis La Plaine, France
- CNRS, UMR 5558, Laboratoire de Biométrie et Biologie Evolutive, Equipe Biostatistique Santé, Villeurbanne, France
| |
Collapse
|
41
|
Chiang SS, Roche S, Contreras C, Del Castillo H, Canales P, Jimenez J, Tintaya K, Becerra MC, Lecca L. Barriers to the treatment of childhood tuberculous infection and tuberculosis disease: a qualitative study. Int J Tuberc Lung Dis 2018; 21:154-160. [PMID: 28234078 DOI: 10.5588/ijtld.16.0624] [Citation(s) in RCA: 31] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Abstract
SETTING In 2012, Peru's National TB Program (NTP) reported approximately 2400 incident cases of tuberculosis (TB) disease in children aged <15 years. Peru's TB burden is concentrated in the Lima metropolitan area, particularly in poor districts such as El Agustino and La Victoria, where this study was conducted. OBJECTIVE To identify barriers to the treatment of childhood tuberculous infection and TB disease in Lima from the perspective of front-line providers and patients' families. DESIGN We conducted 10 semi-structured focus groups with 53 purposefully sampled primary care providers, community health workers, and parents/guardians of pediatric TB patients. We also completed nine in-depth interviews with National TB Program administrators and pulmonologists specializing in TB. Two authors performed inductive thematic analysis and identified emerging themes. RESULTS Four main treatment barriers emerged from the data: 1) dosing errors, 2) time- and labor-intensive preparation and administration of medications, 3) provider concern that isoniazid preventive therapy (IPT) generates isoniazid resistance, and 4) poor adherence to IPT. CONCLUSION Our findings highlight the urgent need for child-friendly formulations, provider and parent/guardian education about IPT, and strategies to promote adherence to IPT, including support and supervision by health workers and/or regimens with fewer doses.
Collapse
Affiliation(s)
- S S Chiang
- Department of Pediatrics, Alpert Medical School, Brown University, Providence, Rhode Island, USA; Center for International Health Research, Rhode Island Hospital, Providence, Rhode Island, USA
| | - S Roche
- Department of Health Care Quality, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
| | - C Contreras
- Socios En Salud (Partners In Health), Lima, Peru
| | | | - P Canales
- Instituto Nacional de Salud del Niño, Lima, Peru
| | - J Jimenez
- Socios En Salud (Partners In Health), Lima, Peru
| | - K Tintaya
- Socios En Salud (Partners In Health), Lima, Peru
| | - M C Becerra
- Socios En Salud (Partners In Health), Lima, Department of Global Health and Social Medicine, Harvard Medical School, Boston, USA; Division of Global Health Equity, Brigham and Women's Hospital, Boston, Massachusetts, USA
| | - L Lecca
- Socios En Salud (Partners In Health), Lima, Peru
| |
Collapse
|
42
|
Kruger N, Stander L, Maqungo S, Roche S, Held M. The Oxford Shoulder Score: Cross-cultural adaptation and translational validation into Afrikaans. SA orthop j 2018. [DOI: 10.17159/2309-8309/2018/v17n1a2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
|
43
|
Peyraga G, Caron D, Lizee T, Metayer Y, Septans AL, Pointreau Y, Denis F, Ganem G, Lafond C, Roche S, Dupuis O. Digestive toxicities after palliative three-dimensional conformal radiation therapy (3D-CRT) for cervico-thoracic spinal metastases. Support Care Cancer 2017; 26:1897-1903. [PMID: 29275524 DOI: 10.1007/s00520-017-4001-4] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2017] [Accepted: 11/24/2017] [Indexed: 11/25/2022]
Abstract
OBJECTIVE The palliative treatment for cervico-thoracic spinal metastases is based on a three-dimensional conformal radiation therapy (3D-CRT). Digestive toxicities are common and cause a clinical impact frequently underestimated in patients. We performed a retrospective study of digestive side effects occurring after palliative 3D-CRT for cervico-thoracic spinal metastases. PATIENTS AND METHODS All patients receiving palliative 3D-CRT at Jean Bernard Center from January 2013 to December 2014 for spinal metastases between the 5th cervical vertebra (C5) and the 12th thoracic vertebra (T12) were eligible. Three-dimensional conformal RT was delivered by a linear accelerator (CLINAC, Varian). Premedication to prevent digestive toxicities was not used. Adverse events ("esophagitis" and "nausea and/or vomiting") were evaluated according to the NCI-CTCae (version 4). RESULTS From January 2013 to December 2014, 128 patients met the study criteria. The median age was 68.6 years [31.8; 88.6]. Most patients (84.4%) received 30 Gy in 10 fractions. The median overall time of treatment was 13 days [3-33]. Forty patients (31.3%) suffered from grade ≥ 2 of "esophagitis" (35 grade 2 (27.4%) and 5 grade 3 (3.9%)). Eight patients (6.3%) suffered from grade ≥ 2 of "nausea and/or vomiting" (6 grade 2 (4.7%), 1 grade 3 (0.8%), and 1 grade 4 (0.8%)). CONCLUSION The high incidence of moderate to severe digestive toxicities after palliative 3D-CRT for cervico-thoracic spinal metastases led to consider static or dynamic intensity-modulated radiation therapy (IMRT) to reduce the dose to organ at risk (the esophagus and stomach). Dosimetric studies and implementation in the clinic should be the next steps.
Collapse
Affiliation(s)
- Guillaume Peyraga
- Department of Radiation Therapy, Jean Bernard Center, 9 Rue Beauverger, 72000, Le Mans, France.
- Department of Radiation Therapy, Integrative Center of Oncology (Paul Papin), 15 rue Bocquel, 49055, Angers Cedex 2, France.
| | - Delphine Caron
- Department of Radiation Therapy, Jean Bernard Center, 9 Rue Beauverger, 72000, Le Mans, France
- Department of Radiation Therapy, Integrative Center of Oncology (Paul Papin), 15 rue Bocquel, 49055, Angers Cedex 2, France
| | - Thibaut Lizee
- Department of Radiation Therapy, Jean Bernard Center, 9 Rue Beauverger, 72000, Le Mans, France
- Department of Radiation Therapy, Integrative Center of Oncology (Paul Papin), 15 rue Bocquel, 49055, Angers Cedex 2, France
| | - Yann Metayer
- Department of Medical Physics, Jean Bernard Center, 9 Rue Beauverger, 72000, Le Mans, France
| | - Anne-Lise Septans
- Department of Medical Biostatistics, Jean Bernard Center, 9 Rue Beauverger, 72000, Le Mans, France
| | - Yoann Pointreau
- Department of Radiation Therapy, Jean Bernard Center, 9 Rue Beauverger, 72000, Le Mans, France
| | - Fabrice Denis
- Department of Radiation Therapy, Jean Bernard Center, 9 Rue Beauverger, 72000, Le Mans, France
| | - Gerard Ganem
- Department of Radiation Therapy, Jean Bernard Center, 9 Rue Beauverger, 72000, Le Mans, France
| | - Cedrik Lafond
- Department of Radiation Therapy, Jean Bernard Center, 9 Rue Beauverger, 72000, Le Mans, France
| | - Sophie Roche
- Department of Radiation Therapy, Jean Bernard Center, 9 Rue Beauverger, 72000, Le Mans, France
| | - Olivier Dupuis
- Department of Radiation Therapy, Jean Bernard Center, 9 Rue Beauverger, 72000, Le Mans, France
| |
Collapse
|
44
|
Poirot I, Laudy V, Rabilloud M, Roche S, Ginhoux T, Kassaï B, Vuillerot C. Prevalence of pain in 240 non-ambulatory children with severe cerebral palsy. Ann Phys Rehabil Med 2017; 60:371-375. [DOI: 10.1016/j.rehab.2017.03.011] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2016] [Revised: 03/27/2017] [Accepted: 03/28/2017] [Indexed: 10/19/2022]
|
45
|
Pointreau Y, Caron D, Septans AL, Denis F, Ganem G, Voog E, Lafond C, Dupuis O, Domont J, Roche S, Bourgeois H, Calais G. Série de radiothérapie en conditions stéréotaxiques de métastases cérébrales précédée ou non d’une irradiation panencéphalique dite prophylactique. Cancer Radiother 2017. [DOI: 10.1016/j.canrad.2017.08.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
46
|
Barkema HW, Orsel K, Nielsen SS, Koets AP, Rutten VPMG, Bannantine JP, Keefe GP, Kelton DF, Wells SJ, Whittington RJ, Mackintosh CG, Manning EJ, Weber MF, Heuer C, Forde TL, Ritter C, Roche S, Corbett CS, Wolf R, Griebel PJ, Kastelic JP, De Buck J. Knowledge gaps that hamper prevention and control of Mycobacterium avium subspecies paratuberculosis infection. Transbound Emerg Dis 2017; 65 Suppl 1:125-148. [PMID: 28941207 DOI: 10.1111/tbed.12723] [Citation(s) in RCA: 71] [Impact Index Per Article: 10.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/09/2017] [Indexed: 12/17/2022]
Abstract
In the last decades, many regional and country-wide control programmes for Johne's disease (JD) were developed due to associated economic losses, or because of a possible association with Crohn's disease. These control programmes were often not successful, partly because management protocols were not followed, including the introduction of infected replacement cattle, because tests to identify infected animals were unreliable, and uptake by farmers was not high enough because of a perceived low return on investment. In the absence of a cure or effective commercial vaccines, control of JD is currently primarily based on herd management strategies to avoid infection of cattle and restrict within-farm and farm-to-farm transmission. Although JD control programmes have been implemented in most developed countries, lessons learned from JD prevention and control programmes are underreported. Also, JD control programmes are typically evaluated in a limited number of herds and the duration of the study is less than 5 year, making it difficult to adequately assess the efficacy of control programmes. In this manuscript, we identify the most important gaps in knowledge hampering JD prevention and control programmes, including vaccination and diagnostics. Secondly, we discuss directions that research should take to address those knowledge gaps.
Collapse
Affiliation(s)
- H W Barkema
- Department of Production Animal Health, Faculty of Veterinary Medicine, University of Calgary, Calgary, AB, Canada
| | - K Orsel
- Department of Production Animal Health, Faculty of Veterinary Medicine, University of Calgary, Calgary, AB, Canada
| | - S S Nielsen
- University of Copenhagen, Copenhagen, Denmark
| | - A P Koets
- Utrecht University, Utrecht, The Netherlands.,Wageningen Bioveterinary Research, Wageningen, The Netherlands
| | - V P M G Rutten
- Utrecht University, Utrecht, The Netherlands.,Department of Veterinary Tropical Diseases, Faculty of Veterinary Science, University of Pretoria, Private Bag X04, Onderstepoort, 0110, South Africa
| | | | - G P Keefe
- University of Prince Edward Island, Charlottetown, Canada
| | | | - S J Wells
- University of Minnesota, Minneapolis, MN, USA
| | | | | | | | - M F Weber
- GD Animal Health, Deventer, The Netherlands
| | - C Heuer
- Massey University, Palmerston North, New Zealand
| | | | - C Ritter
- Department of Production Animal Health, Faculty of Veterinary Medicine, University of Calgary, Calgary, AB, Canada
| | - S Roche
- University of Guelph, Guelph, Canada
| | - C S Corbett
- Department of Production Animal Health, Faculty of Veterinary Medicine, University of Calgary, Calgary, AB, Canada
| | - R Wolf
- Amt der Steiermärkischen Landesregierung, Graz, Austria
| | | | - J P Kastelic
- Department of Production Animal Health, Faculty of Veterinary Medicine, University of Calgary, Calgary, AB, Canada
| | - J De Buck
- Department of Production Animal Health, Faculty of Veterinary Medicine, University of Calgary, Calgary, AB, Canada
| |
Collapse
|
47
|
Voog E, Campion L, du Rusquec P, Bourgeois H, Domont J, Denis F, Emmanuel E, Dupuis O, Ganem G, Lafont C, Le Du K, Pavluc E, Pointreau Y, Roche S, Juhel-Voog L, Zinger M, Solal-Celigny P. Totally implantable venous access ports: a prospective long-term study of early and late complications in adult patients with cancer. Support Care Cancer 2017; 26:81-89. [DOI: 10.1007/s00520-017-3816-3] [Citation(s) in RCA: 34] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2017] [Accepted: 07/03/2017] [Indexed: 11/28/2022]
|
48
|
Vanhems P, Baghdadi Y, Roche S, Bénet T, Regis C, Lina B, Robert O, Voirin N, Ecochard R, Amour S. Influenza vaccine effectiveness among healthcare workers in comparison to hospitalized patients: A 2004-2009 case-test, negative-control, prospective study. Hum Vaccin Immunother 2016; 12:485-90. [PMID: 26327520 DOI: 10.1080/21645515.2015.1079677] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
Abstract
The objective of this study was to calculate Vaccine Effectiveness (VE) in healthcare workers (HCW) and to compare VE between patients and HCW. A case-control investigation based on the prospective study was conducted between 2004 and 2009 in a teaching hospital. All HCW with influenza-like illness (ILI) from participating units (n = 24) were included, and vaccination status was characterized by interview. A total of 150 HCW presented ILI; 130 (87%) were female, 27 (18%) were positive for influenza, and 42 (28%) were vaccinated. Adjusted VE was 89% (95% CI 39 to 98). Among patients, adjusted VE was 42% (95% CI -39 to 76). The difference of VE (VEhcw - VEpat) was 46.15% (95% CI 2.41 to 144). The VE ratio (VEhcw / VEpat) was 2.09 (95% CI -1.60 to 134.17). Influenza VE differed between HCW and patients when the flu season was taken into account. This finding confirms the major impact of host determinants on influenza VE.
Collapse
Affiliation(s)
- P Vanhems
- a Service d'Hygiène; Epidémiologie et Prévention; Groupement hospitalier Edouard Herriot; Hospices Civils de Lyon ; Lyon , France.,b Laboratoire d'Epidémiologie et Santé Publique; Université Claude Bernard Lyon 1; Université de Lyon ; Lyon , France
| | - Y Baghdadi
- b Laboratoire d'Epidémiologie et Santé Publique; Université Claude Bernard Lyon 1; Université de Lyon ; Lyon , France
| | - S Roche
- c Service de Biostatistique; Groupement hospitalier Edouard Herriot; Hospices Civils de Lyon ; Lyon , France.,d Equipe Biostatistique-Santé; Center National de la Recherche Scientifique-Unité Mixte de Recherche 5558; Université Claude Bernard Lyon 1; Université de Lyon ; Villeurbanne , France
| | - T Bénet
- a Service d'Hygiène; Epidémiologie et Prévention; Groupement hospitalier Edouard Herriot; Hospices Civils de Lyon ; Lyon , France
| | - C Regis
- b Laboratoire d'Epidémiologie et Santé Publique; Université Claude Bernard Lyon 1; Université de Lyon ; Lyon , France
| | - B Lina
- e Centre de Biologie et Pathologie Est; Center National de référence des virus influenza région Sud; Groupement Hospitalier Est; Hospices Civils de Lyon ; Bron , France.,f Département de Virologie ; Université Lyon 1; Université de Lyon ; Bron , France
| | - O Robert
- g Service de médecine Préventive du Personnel; Groupement hospitalier Edouard Herriot; Hospices Civils de Lyon ; Lyon , France
| | - N Voirin
- a Service d'Hygiène; Epidémiologie et Prévention; Groupement hospitalier Edouard Herriot; Hospices Civils de Lyon ; Lyon , France
| | - R Ecochard
- c Service de Biostatistique; Groupement hospitalier Edouard Herriot; Hospices Civils de Lyon ; Lyon , France.,d Equipe Biostatistique-Santé; Center National de la Recherche Scientifique-Unité Mixte de Recherche 5558; Université Claude Bernard Lyon 1; Université de Lyon ; Villeurbanne , France
| | - S Amour
- a Service d'Hygiène; Epidémiologie et Prévention; Groupement hospitalier Edouard Herriot; Hospices Civils de Lyon ; Lyon , France
| |
Collapse
|
49
|
Jordaan P, Roche S, Maqungo S. Computerised Tomographic Angiography (CTA) in extremity trauma - A level one hospital experience. S AFR J SURG 2016; 54:11-16. [PMID: 28272850] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
INTRODUCTION The aim of this study was to audit the use of Computerised Tomographic Angiography (CTA) in assessing extremity vascular injuries at our institution and to compare it to international standards. The primary aim was to assess the number of CTAs performed and the indications for doing them. The secondary aim was to look at CTA results and clinical findings and to correlate the two. METHOD This is a retrospective review of all patients aged 13 years and older who had CTA performed for suspected extremity vascular injuries due to blunt trauma or gunshot injuries, who presented from January 2012 to December 2012. RESULTS Two hundred and eighty five (285) CTAs were performed in 2012 and 137 met our inclusion criteria. Eleven cases were excluded due to insufficient data, leaving a total of 126 cases suitable for analysis. Eighty three patients (66%) had a normal CTA. The indications for CTA were as follows: decreased pulse in 46 patients (42%), absent pulse in 19 patients (17%), presumed knee dislocation in 18 patients (16%), injuries in the proximity of large vessels in 12 patients (11%), haematoma in 8 patients (7%), bleeding in 5 patients (4%) and an abnormal Doppler in 2 patients (2%). When comparing pulse examination to CTA results, the clinical assessment of pulses had a sensitivity of 74.4%, specificity of 53.7%, positive predictive value (PPV) of 45.7% and a negative predictive value (NPV) of 80%. CONCLUSION Incorrect indications are being used when ordering a CTA in extremity vascular trauma. Clinical examination is suboptimal and not a reliable indicator of vascular injury in our setting, leading to a lower threshold for ordering a CTA.
Collapse
Affiliation(s)
- P Jordaan
- Registrar, Orthopaedic Surgery, Groote Schuur Hospital, University of Cape Town
| | - S Roche
- Consultant Orthopaedic Surgeon, Groote Schuur Hospital
| | - S Maqungo
- Consultant Orthopaedic Surgeon, Groote Schuur Hospital
| |
Collapse
|
50
|
Van Tuan D, Marmolejo-Tejada JM, Waintal X, Nikolić BK, Valenzuela SO, Roche S. Spin Hall Effect and Origins of Nonlocal Resistance in Adatom-Decorated Graphene. Phys Rev Lett 2016; 117:176602. [PMID: 27824472 DOI: 10.1103/physrevlett.117.176602] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/19/2016] [Indexed: 06/06/2023]
Abstract
Recent experiments reporting an unexpectedly large spin Hall effect (SHE) in graphene decorated with adatoms have raised a fierce controversy. We apply numerically exact Kubo and Landauer-Büttiker formulas to realistic models of gold-decorated disordered graphene (including adatom clustering) to obtain the spin Hall conductivity and spin Hall angle, as well as the nonlocal resistance as a quantity accessible to experiments. Large spin Hall angles of ∼0.1 are obtained at zero temperature, but their dependence on adatom clustering differs from the predictions of semiclassical transport theories. Furthermore, we find multiple background contributions to the nonlocal resistance, some of which are unrelated to the SHE or any other spin-dependent origin, as well as a strong suppression of the SHE at room temperature. This motivates us to design a multiterminal graphene geometry which suppresses these background contributions and could, therefore, quantify the upper limit for spin-current generation in two-dimensional materials.
Collapse
Affiliation(s)
- D Van Tuan
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and The Barcelona Institute of Science and Technology, Campus UAB, Bellaterra, 08193 Barcelona, Spain
- Department of Electrical and Computer Engineering, University of Rochester, Rochester, New York 14627, USA
| | - J M Marmolejo-Tejada
- Department of Physics and Astronomy, University of Delaware, Newark, Delaware 19716-2570, USA
- School of Electrical and Electronics Engineering, Universidad del Valle, Cali AA 25360, Colombia
| | - X Waintal
- Univ. Grenoble Alpes, INAC-PHELIQS, F-38000 Grenoble, France and CEA, INAC-PHELIQS, F-38000 Grenoble, France
| | - B K Nikolić
- Department of Physics and Astronomy, University of Delaware, Newark, Delaware 19716-2570, USA
| | - S O Valenzuela
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and The Barcelona Institute of Science and Technology, Campus UAB, Bellaterra, 08193 Barcelona, Spain
- ICREA-Institució Catalana de Recerca i Estudis Avançats, 08010 Barcelona, Spain
| | - S Roche
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and The Barcelona Institute of Science and Technology, Campus UAB, Bellaterra, 08193 Barcelona, Spain
- ICREA-Institució Catalana de Recerca i Estudis Avançats, 08010 Barcelona, Spain
| |
Collapse
|